{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 74621, "items": [{"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:18:58Z", "timestamp": 1575105538870}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592590446", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-044-6:61", "type": "book-chapter", "created": {"date-parts": [[2003, 11, 14]], "date-time": "2003-11-14T23:27:46Z", "timestamp": 1068852466000}, "page": "61-71", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Murine Natural Killer Cells and Hybrid Resistance to Hemopoietic Cells In Vivo"], "prefix": "10.1007", "author": [{"given": "Jingxuan", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Thaddeus", "family": "George", "sequence": "additional", "affiliation": []}, {"given": "Gene A.", "family": "Devora", "sequence": "additional", "affiliation": []}, {"given": "P. V.", "family": "Sivakumar", "sequence": "additional", "affiliation": []}, {"given": "Colleen", "family": "Davenport", "sequence": "additional", "affiliation": []}, {"given": "Wayne C.", "family": "Lai", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Schatzle", "sequence": "additional", "affiliation": []}, {"given": "Vinay", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Natural Killer Cell Protocols"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T14:19:18Z", "timestamp": 1357222758000}, "score": 34.519077, "issued": {"date-parts": [[null]]}, "ISBN": ["1592590446"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-044-6:61"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:18:58Z", "timestamp": 1575105538897}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592590446", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-044-6:73", "type": "book-chapter", "created": {"date-parts": [[2003, 11, 14]], "date-time": "2003-11-14T23:27:46Z", "timestamp": 1068852466000}, "page": "73-79", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Hybrid Resistance by Mouse NK Cells In Vitro"], "prefix": "10.1007", "author": [{"given": "P. V.", "family": "Sivakumar", "sequence": "first", "affiliation": []}, {"given": "Thaddeus", "family": "George", "sequence": "additional", "affiliation": []}, {"given": "Igor J.", "family": "Puzanov", "sequence": "additional", "affiliation": []}, {"given": "Noelle S.", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "Susan", "family": "Stepp", "sequence": "additional", "affiliation": []}, {"given": "Jingxuan", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Schatzle", "sequence": "additional", "affiliation": []}, {"given": "Wayne C.", "family": "Lai", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Natural Killer Cell Protocols"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T14:19:19Z", "timestamp": 1357222759000}, "score": 29.405243, "issued": {"date-parts": [[null]]}, "ISBN": ["1592590446"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-044-6:73"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:32:46Z", "timestamp": 1575109966844}, "reference-count": 25, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplantation"], "published-print": {"date-parts": [[1997, 2]]}, "DOI": "10.1097/00007890-199702150-00019", "type": "journal-article", "created": {"date-parts": [[2003, 12, 2]], "date-time": "2003-12-02T10:25:43Z", "timestamp": 1070360743000}, "page": "444-449", "source": "Crossref", "is-referenced-by-count": 1, "title": ["MURINE MARROW COEXPRESSING H2-Dsp2 AND H2-Db ON HOST NATURAL KILLER CELL REJECTION1"], "prefix": "10.1097", "volume": "63", "author": [{"given": "Jingxuan", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Charles L.", "family": "Sentman", "sequence": "additional", "affiliation": []}, {"given": "Vinay", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Transplantation"], "language": "en", "deposited": {"date-parts": [[2018, 3, 27]], "date-time": "2018-03-27T02:38:45Z", "timestamp": 1522118325000}, "score": 29.375565, "subtitle": [""], "issued": {"date-parts": [[1997, 2]]}, "references-count": 25, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00007890-199702150-00019", "ISSN": ["0041-1337"], "issn-type": [{"value": "0041-1337", "type": "print"}], "subject": ["Transplantation"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:46:04Z", "timestamp": 1574873164844}, "reference-count": 187, "publisher": "InTech", "isbn-type": [{"value": "9789535136712", "type": "print"}, {"value": "9789535136729", "type": "electronic"}], "license": [{"URL": "https://creativecommons.org/licenses/by/3.0/legalcode", "start": {"date-parts": [[2017, 12, 13]], "date-time": "2017-12-13T00:00:00Z", "timestamp": 1513123200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/intechopen.69684", "type": "book-chapter", "created": {"date-parts": [[2017, 12, 13]], "date-time": "2017-12-13T13:03:26Z", "timestamp": 1513170206000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Donor Natural Killer Cells and Their Therapeutic Potential in Allogeneic Hematopoietic Stem Cell Transplantation"], "prefix": "10.5772", "author": [{"given": "Bo", "family": "Hu", "sequence": "first", "affiliation": []}, {"given": "Haiyan", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2017, 12, 13]]}, "reference": [{"key": "ref=1", "unstructured": "Hamilton BK, Copelan EA. Concise review: The role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem cells. 2012;30(8):1581-1586", "DOI": "10.1002/stem.1140", "doi-asserted-by": "crossref"}, {"key": "ref=2", "unstructured": "Parkman R. Getting a handle on graft-versus-host disease. The New England Journal of Medicine. 2004;350(6):614-615", "DOI": "10.1056/NEJMcibr033175", "doi-asserted-by": "crossref"}, {"key": "ref=3", "unstructured": "Beilhack A, Schulz S, Baker J et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106(3):1113-1122", "DOI": "10.1182/blood-2005-02-0509", "doi-asserted-by": "crossref"}, {"key": "ref=4", "unstructured": "Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nature Reviews Immunology. 2007;7(5):329-339", "DOI": "10.1038/nri2073", "doi-asserted-by": "crossref"}, {"key": "ref=5", "unstructured": "Terme M, Ullrich E, Delahaye NF et al. Natural killer cell-directed therapies: Moving from unexpected results to successful strategies. Nature Immunology 2008;9(5):486-494", "DOI": "10.1038/ni1580", "doi-asserted-by": "crossref"}, {"key": "ref=6", "unstructured": "Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100", "DOI": "10.1126/science.1068440", "doi-asserted-by": "crossref"}, {"key": "ref=7", "unstructured": "Olson JA, Zeiser R, Beilhack A et al. Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation. Journal of Immunology. 2009;183(5):3219-3228", "DOI": "10.4049/jimmunol.0804268", "doi-asserted-by": "crossref"}, {"key": "ref=8", "unstructured": "Symons HJ, Fuchs EJ. Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors. Bone Marrow Transplantation. 2008;42(6):365-377", "DOI": "10.1038/bmt.2008.215", "doi-asserted-by": "crossref"}, {"key": "ref=9", "unstructured": "Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends Immunology. 2013;34(12):573-582", "DOI": "10.1016/j.it.2013.07.005", "doi-asserted-by": "crossref"}, {"key": "ref=10", "unstructured": "Koehl U, Kalberer C, Spanholtz J et al. Advances in clinical NK cell studies: Donor selection, manufacturing and quality control. Oncoimmunology. 2016;5(4):e1115178", "DOI": "10.1080/2162402X.2015.1115178", "doi-asserted-by": "crossref"}, {"key": "ref=11", "unstructured": "Klingemann H. Challenges of cancer therapy with natural killer cells. Cytotherapy. 2015;17(3):245-249", "DOI": "10.1016/j.jcyt.2014.09.007", "doi-asserted-by": "crossref"}, {"key": "ref=12", "unstructured": "Schonberg K, Fischer JC, Kogler G, Uhrberg M. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood. 2011;117(19):5152-5156", "DOI": "10.1182/blood-2011-02-334441", "doi-asserted-by": "crossref"}, {"key": "ref=13", "unstructured": "Fujisaki H, Kakuda H, Shimasaki N et al. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Research. 2009;69(9):4010-4017", "DOI": "10.1158/0008-5472.CAN-08-3712", "doi-asserted-by": "crossref"}, {"key": "ref=14", "unstructured": "Berg M, Lundqvist A, McCoy P, Jr. et al. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy. 2009;11(3):341-355", "DOI": "10.1080/14653240902807034", "doi-asserted-by": "crossref"}, {"key": "ref=15", "unstructured": "Spanholtz J, Preijers F, Tordoir M et al. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process. PloS One. 2011;6(6):e20740", "DOI": "10.1371/journal.pone.0020740", "doi-asserted-by": "crossref"}, {"key": "ref=16", "unstructured": "Tonn T, Schwabe D, Klingemann HG et al. Treatment of patients with advanced cancer with the natural killer cell line NK-92. Cytotherapy. 2013;15(12):1563-1570", "DOI": "10.1016/j.jcyt.2013.06.017", "doi-asserted-by": "crossref"}, {"key": "ref=17", "unstructured": "Tam YK, Martinson JA, Doligosa K, Klingemann HG. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy. Cytotherapy. 2003;5(3):259-272", "DOI": "10.1080/14653240310001523", "doi-asserted-by": "crossref"}, {"key": "ref=18", "unstructured": "Binyamin L, Alpaugh RK, Hughes TL et al. Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy. Journal of Immunology. 2008;180(9):6392-6401", "DOI": "10.4049/jimmunol.180.9.6392", "doi-asserted-by": "crossref"}, {"key": "ref=19", "unstructured": "Clemenceau B, Vivien R, Pellat C et al. The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential. mAbs. 2013;5(4):587-594", "DOI": "10.4161/mabs.25077", "doi-asserted-by": "crossref"}, {"key": "ref=20", "unstructured": "Romanski A, Uherek C, Bug G et al. CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies. Journal of Cellular and Molecular Medicine. 2016;20(7):1287-1294", "DOI": "10.1111/jcmm.12810", "doi-asserted-by": "crossref"}, {"key": "ref=21", "unstructured": "Paust S, Gill HS, Wang BZ et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nature Immunology. 2010;11(12):1127-1135", "DOI": "10.1038/ni.1953", "doi-asserted-by": "crossref"}, {"key": "ref=22", "unstructured": "Kuijpers TW, Baars PA, Dantin C et al. Human NK cells can control CMV infection in the absence of T cells. Blood. 2008;112(3):914-915", "DOI": "10.1182/blood-2008-05-157354", "doi-asserted-by": "crossref"}, {"key": "ref=23", "unstructured": "Cheng TP, French AR, Plougastel BF et al. Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics. 2008;60(10):565-573", "DOI": "10.1007/s00251-008-0313-3", "doi-asserted-by": "crossref"}, {"key": "ref=24", "unstructured": "Cooper MA, Elliott JM, Keyel PA et al. Cytokine-induced memory-like natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(6):1915-1919", "DOI": "10.1073/pnas.0813192106", "doi-asserted-by": "crossref"}, {"key": "ref=25", "unstructured": "Keppel MP, Yang L, Cooper MA. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. Journal of Immunology. 2013;190(9):4754-4762", "DOI": "10.4049/jimmunol.1201742", "doi-asserted-by": "crossref"}, {"key": "ref=26", "unstructured": "Romee R, Schneider SE, Leong JW et al. Cytokine activation induces human memory-like NK cells. Blood. 2012;120(24):4751-4760", "DOI": "10.1182/blood-2012-04-419283", "doi-asserted-by": "crossref"}, {"key": "ref=27", "unstructured": "Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. International Journal of Cancer Journal International du Cancer. 1975;16(2):216-229", "DOI": "10.1002/ijc.2910160204", "doi-asserted-by": "crossref"}, {"key": "ref=28", "unstructured": "Kiessling R, Klein E, Wigzell H. \u201cNatural\u201d killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. European Journal of Immunology. 1975;5(2):112-117", "DOI": "10.1002/eji.1830050208", "doi-asserted-by": "crossref"}, {"key": "ref=29", "unstructured": "Montaldo E, Vacca P, Moretta L, Mingari MC. Development of human natural killer cells and other innate lymphoid cells. Seminars in Immunology. 2014;26(2):107-113", "DOI": "10.1016/j.smim.2014.01.006", "doi-asserted-by": "crossref"}, {"key": "ref=30", "unstructured": "Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469", "DOI": "10.1182/blood-2007-09-077438", "doi-asserted-by": "crossref"}, {"key": "ref=31", "unstructured": "Jacobs R, Hintzen G, Kemper A et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. European Journal of Immunology. 2001;31(10):3121-3127", "DOI": "10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4", "doi-asserted-by": "crossref"}, {"key": "ref=32", "unstructured": "Robertson MJ, Manley TJ, Donahue C et al. Costimulatory signals are required for optimal proliferation of human natural killer cells. Journal of Immunology. 1993;150(5):1705-1714"}, {"key": "ref=33", "unstructured": "Baume DM, Robertson MJ, Levine H et al. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. European Journal of Immunology. 1992;22(1):1-6", "DOI": "10.1002/eji.1830220102", "doi-asserted-by": "crossref"}, {"key": "ref=34", "unstructured": "Moretta L, Locatelli F, Pende D et al. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood. 2011;117(3):764-771", "DOI": "10.1182/blood-2010-08-264085", "doi-asserted-by": "crossref"}, {"key": "ref=35", "unstructured": "Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997;7(6):739-751", "DOI": "10.1016/S1074-7613(00)80393-3", "doi-asserted-by": "crossref"}, {"key": "ref=36", "unstructured": "Cooley S, Trachtenberg E, Bergemann TL et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 2009;113(3):726-732", "DOI": "10.1182/blood-2008-07-171926", "doi-asserted-by": "crossref"}, {"key": "ref=37", "unstructured": "Pyo CW, Guethlein LA, Vu Q et al. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PloS One. 2010;5(12):e15115", "DOI": "10.1371/journal.pone.0015115", "doi-asserted-by": "crossref"}, {"key": "ref=38", "unstructured": "Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Reviews. 2006;214(73-91)", "DOI": "10.1111/j.1600-065X.2006.00457.x", "doi-asserted-by": "crossref"}, {"key": "ref=39", "unstructured": "Pende D, Cantoni C, Rivera P et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. European Journal of Immunology. 2001;31(4):1076-1086", "DOI": "10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y", "doi-asserted-by": "crossref"}, {"key": "ref=40", "unstructured": "Cosman D, Mullberg J, Sutherland CL et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14(2):123-133", "DOI": "10.1016/S1074-7613(01)00095-4", "doi-asserted-by": "crossref"}, {"key": "ref=41", "unstructured": "Hershkovitz O, Rosental B, Rosenberg LA et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. Journal of Immunology. 2009;183(4):2610-2621", "DOI": "10.4049/jimmunol.0802806", "doi-asserted-by": "crossref"}, {"key": "ref=42", "unstructured": "Pende D, Parolini S, Pessino A et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. The Journal of Experimental Medicine. 1999;190(10):1505-1516", "DOI": "10.1084/jem.190.10.1505", "doi-asserted-by": "crossref"}, {"key": "ref=43", "unstructured": "Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. The Journal of Experimental Medicine. 1998;187(12):2065-2072", "DOI": "10.1084/jem.187.12.2065", "doi-asserted-by": "crossref"}, {"key": "ref=44", "unstructured": "Mandelboim O, Lieberman N, Lev M et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409(6823):1055-1060", "DOI": "10.1038/35059110", "doi-asserted-by": "crossref"}, {"key": "ref=45", "unstructured": "Baychelier F, Sennepin A, Ermonval M et al. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood. 2013;122(17):2935-2942", "DOI": "10.1182/blood-2013-03-489054", "doi-asserted-by": "crossref"}, {"key": "ref=46", "unstructured": "Yokoyama WM. Specific and non-specific natural killer cell responses to viral infection. Advances in Experimental Medicine and Biology. 2005;560(57-61)", "DOI": "10.1007/0-387-24180-9_8", "doi-asserted-by": "crossref"}, {"key": "ref=47", "unstructured": "Torelli GF, Guarini A, Palmieri G et al. Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission. British Journal of Haematology. 2002;116(2):299-307", "DOI": "10.1046/j.1365-2141.2002.03277.x", "doi-asserted-by": "crossref"}, {"key": "ref=48", "unstructured": "Trapani JA, Smyth MJ. Killing by cytotoxic T cells and natural killer cells: Multiple granule serine proteases as initiators of DNA fragmentation. Immunology and cell biology 1993;71(Pt 3):201-208", "DOI": "10.1038/icb.1993.22", "doi-asserted-by": "crossref"}, {"key": "ref=49", "unstructured": "Screpanti V, Wallin RP, Ljunggren HG, Grandien A. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. Journal of Immunology. 2001;167(4):2068-2073", "DOI": "10.4049/jimmunol.167.4.2068", "doi-asserted-by": "crossref"}, {"key": "ref=50", "unstructured": "Smyth MJ, Takeda K, Hayakawa Y et al. Nature\u2019s TRAIL\u2014on a path to cancer immunotherapy. Immunity. 2003;18(1):1-6", "DOI": "10.1016/S1074-7613(02)00502-2", "doi-asserted-by": "crossref"}, {"key": "ref=51", "unstructured": "Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. Journal of Immunology. 1988;141(10):3478-3485"}, {"key": "ref=52", "unstructured": "Gerosa F, Baldani-Guerra B, Nisii C et al. Reciprocal activating interaction between natural killer cells and dendritic cells. The Journal of Experimental Medicine. 2002;195(3):327-333", "DOI": "10.1084/jem.20010938", "doi-asserted-by": "crossref"}, {"key": "ref=53", "unstructured": "Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nature Immunology. 2004;5(12):1260-1265", "DOI": "10.1038/ni1138", "doi-asserted-by": "crossref"}, {"key": "ref=54", "unstructured": "Montaldo E, Del Zotto G, Della Chiesa M et al. Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. Cytometry Part A: The Journal of the International Society for Analytical Cytology 2013;83(8):702-713", "DOI": "10.1002/cyto.a.22302", "doi-asserted-by": "crossref"}, {"key": "ref=55", "unstructured": "Boos MD, Yokota Y, Eberl G, Kee BL. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. The Journal of Experimental Medicine. 2007;204(5):1119-1130", "DOI": "10.1084/jem.20061959", "doi-asserted-by": "crossref"}, {"key": "ref=56", "unstructured": "Aliahmad P, de la Torre B, Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nature Immunology. 2010;11(10):945-952", "DOI": "10.1038/ni.1930", "doi-asserted-by": "crossref"}, {"key": "ref=57", "unstructured": "Gascoyne DM, Long E, Veiga-Fernandes H et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nature Immunology. 2009;10(10):1118-1124", "DOI": "10.1038/ni.1787", "doi-asserted-by": "crossref"}, {"key": "ref=58", "unstructured": "Kamizono S, Duncan GS, Seidel MG et al. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. The Journal of Experimental Medicine. 2009;206(13):2977-2986", "DOI": "10.1084/jem.20092176", "doi-asserted-by": "crossref"}, {"key": "ref=59", "unstructured": "Gordon SM, Chaix J, Rupp LJ et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36(1):55-67", "DOI": "10.1016/j.immuni.2011.11.016", "doi-asserted-by": "crossref"}, {"key": "ref=60", "unstructured": "Pradier A, Simonetta F, Waldvogel S et al. Modulation of T-bet and eomes during maturation of peripheral blood NK cells does not depend on licensing/educating KIR. Frontiers Immunology. 2016;7:299", "DOI": "10.3389/fimmu.2016.00299", "doi-asserted-by": "crossref"}, {"key": "ref=61", "unstructured": "Minagawa M, Watanabe H, Miyaji C et al. Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor beta-chain-deficient mice. Journal of Immunology. 2002;169(8):4153-4160", "DOI": "10.4049/jimmunol.169.8.4153", "doi-asserted-by": "crossref"}, {"key": "ref=62", "unstructured": "Yu H, Fehniger TA, Fuchshuber P et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood. 1998;92(10):3647-3657"}, {"key": "ref=63", "unstructured": "Carson WE, Haldar S, Baiocchi RA et al. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(16):7553-7557", "DOI": "10.1073/pnas.91.16.7553", "doi-asserted-by": "crossref"}, {"key": "ref=64", "unstructured": "Bulfone-Paus S, Bulanova E, Budagian V, Paus R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology. 2006;28(4):362-377", "DOI": "10.1002/bies.20380", "doi-asserted-by": "crossref"}, {"key": "ref=65", "unstructured": "Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood. 2010;115(11):2167-2176", "DOI": "10.1182/blood-2009-08-238469", "doi-asserted-by": "crossref"}, {"key": "ref=66", "unstructured": "De Maria A, Bozzano F, Cantoni C, Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(2):728-732", "DOI": "10.1073/pnas.1012356108", "doi-asserted-by": "crossref"}, {"key": "ref=67", "unstructured": "Hallett WH, Murphy WJ. Positive and negative regulation of Natural Killer cells: Therapeutic implications. Seminars in Cancer Biology. 2006;16(5):367-382", "DOI": "10.1016/j.semcancer.2006.07.003", "doi-asserted-by": "crossref"}, {"key": "ref=68", "unstructured": "Ferlazzo G, Thomas D, Lin SL et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. Journal of Immunology. 2004;172(3):1455-1462", "DOI": "10.4049/jimmunol.172.3.1455", "doi-asserted-by": "crossref"}, {"key": "ref=69", "unstructured": "Fehniger TA, Cooper MA, Nuovo GJ et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052-3057", "DOI": "10.1182/blood-2002-09-2876", "doi-asserted-by": "crossref"}, {"key": "ref=70", "unstructured": "Romagnani C, Juelke K, Falco M et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. Journal of Immunology. 2007;178(8):4947-4955", "DOI": "10.4049/jimmunol.178.8.4947", "doi-asserted-by": "crossref"}, {"key": "ref=71", "unstructured": "Zhang J, Chen Z, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: Maternal care before birth? Cellular &amp; Molecular Immunology. 2011;8(1):1-11", "DOI": "10.1038/cmi.2010.38", "doi-asserted-by": "crossref"}, {"key": "ref=72", "unstructured": "Macallan DC, Borghans JA, Asquith B. Human T cell memory: A dynamic view. Vaccines. 2017;5(1)", "DOI": "10.3390/vaccines5010005", "doi-asserted-by": "crossref"}, {"key": "ref=73", "unstructured": "O\u2019Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunology. 2006;7(5):507-516", "DOI": "10.1038/ni1332", "doi-asserted-by": "crossref"}, {"key": "ref=74", "unstructured": "Peng H, Jiang X, Chen Y et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. The Journal of Clinical Investigation. 2013;123(4):1444-1456", "DOI": "10.1172/JCI66381", "doi-asserted-by": "crossref"}, {"key": "ref=75", "unstructured": "Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457(7229):557-561", "DOI": "10.1038/nature07665", "doi-asserted-by": "crossref"}, {"key": "ref=76", "unstructured": "Nabekura T, Kanaya M, Shibuya A et al. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity. 2014;40(2):225-234", "DOI": "10.1016/j.immuni.2013.12.011", "doi-asserted-by": "crossref"}, {"key": "ref=77", "unstructured": "Madera S, Rapp M, Firth MA et al. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. The Journal of Experimental Medicine. 2016;213(2):225-233", "DOI": "10.1084/jem.20150712", "doi-asserted-by": "crossref"}, {"key": "ref=78", "unstructured": "Beaulieu AM, Zawislak CL, Nakayama T, Sun JC. The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nature Immunology. 2014;15(6):546-553", "DOI": "10.1038/ni.2876", "doi-asserted-by": "crossref"}, {"key": "ref=79", "unstructured": "Lopez-Verges S, Milush JM, Schwartz BS et al. Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14725-14732", "DOI": "10.1073/pnas.1110900108", "doi-asserted-by": "crossref"}, {"key": "ref=80", "unstructured": "Foley B, Cooley S, Verneris MR et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 2012;119(11):2665-2674", "DOI": "10.1182/blood-2011-10-386995", "doi-asserted-by": "crossref"}, {"key": "ref=81", "unstructured": "Rolle A, Brodin P. Immune adaptation to environmental influence: The case of NK cells and HCMV. Trends Immunology. 2016;37(3):233-243", "DOI": "10.1016/j.it.2016.01.005", "doi-asserted-by": "crossref"}, {"key": "ref=82", "unstructured": "Luetke-Eversloh M, Hammer Q, Durek P et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathogens. 2014;10(10):e1004441", "DOI": "10.1371/journal.ppat.1004441", "doi-asserted-by": "crossref"}, {"key": "ref=83", "unstructured": "Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annual Review of Immunology. 2001;19:291-330", "DOI": "10.1146/annurev.immunol.19.1.291", "doi-asserted-by": "crossref"}, {"key": "ref=84", "unstructured": "Raulet DH, Held W, Correa I et al. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunology Reviews. 1997;155:41-52", "DOI": "10.1111/j.1600-065X.1997.tb00938.x", "doi-asserted-by": "crossref"}, {"key": "ref=85", "unstructured": "Zimmer J, Donato L, Hanau D et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). The Journal of Experimental Medicine. 1998;187(1):117-122", "DOI": "10.1084/jem.187.1.117", "doi-asserted-by": "crossref"}, {"key": "ref=86", "unstructured": "Zimmer J, Donato L, Hanau D et al. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression. European Journal of Immunology. 1999;29(4):1286-1291", "DOI": "10.1002/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L", "doi-asserted-by": "crossref"}, {"key": "ref=87", "unstructured": "Orr MT, Murphy WJ, Lanier LL. \u2018Unlicensed\u2019 natural killer cells dominate the response to cytomegalovirus infection. Nature Immunology. 2010;11(4):321-327", "DOI": "10.1038/ni.1849", "doi-asserted-by": "crossref"}, {"key": "ref=88", "unstructured": "Kim S, Poursine-Laurent J, Truscott SM et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709-713", "DOI": "10.1038/nature03847", "doi-asserted-by": "crossref"}, {"key": "ref=89", "unstructured": "Pende D, Marcenaro S, Falco M et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009;113(13):3119-3129", "DOI": "10.1182/blood-2008-06-164103", "doi-asserted-by": "crossref"}, {"key": "ref=90", "unstructured": "Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood. 1999;93(2):467-480"}, {"key": "ref=91", "unstructured": "Bjorklund AT, Schaffer M, Fauriat C et al. NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood. 2010;115(13):2686-2694", "DOI": "10.1182/blood-2009-07-229740", "doi-asserted-by": "crossref"}, {"key": "ref=92", "unstructured": "Nguyen S, Kuentz M, Vernant JP et al. Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation. Leukemia. 2008;22(2):344-352", "DOI": "10.1038/sj.leu.2405041", "doi-asserted-by": "crossref"}, {"key": "ref=93", "unstructured": "Eissens DN, Schaap NP, Preijers FW et al. CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A. Leukemia. 2010;24(3):583-591", "DOI": "10.1038/leu.2009.269", "doi-asserted-by": "crossref"}, {"key": "ref=94", "unstructured": "Shilling HG, McQueen KL, Cheng NW et al. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood. 2003;101(9):3730-3740", "DOI": "10.1182/blood-2002-08-2568", "doi-asserted-by": "crossref"}, {"key": "ref=95", "unstructured": "Foley B, Cooley S, Verneris MR et al. NK cell education after allogeneic transplantation: Dissociation between recovery of cytokine-producing and cytotoxic functions. Blood. 2011;118(10):2784-2792", "DOI": "10.1182/blood-2011-04-347070", "doi-asserted-by": "crossref"}, {"key": "ref=96", "unstructured": "Vago L, Forno B, Sormani MP et al. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood. 2008;112(8):3488-3499", "DOI": "10.1182/blood-2007-07-103325", "doi-asserted-by": "crossref"}, {"key": "ref=97", "unstructured": "Gleason MK, Lenvik TR, McCullar V et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood. 2012;119(13):3064-3072", "DOI": "10.1182/blood-2011-06-360321", "doi-asserted-by": "crossref"}, {"key": "ref=98", "unstructured": "Fehniger TA, Shah MH, Turner MJ et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. Journal of Immunology. 1999;162(8):4511-4520"}, {"key": "ref=99", "unstructured": "Locatelli F, Pende D, Maccario R et al. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference. Clinical Immunology. 2009;133(2):171-178", "DOI": "10.1016/j.clim.2009.04.009", "doi-asserted-by": "crossref"}, {"key": "ref=100", "unstructured": "Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94(1):333-339"}, {"key": "ref=101", "unstructured": "Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood. 2002;100(10):3825-3827", "DOI": "10.1182/blood-2002-04-1197", "doi-asserted-by": "crossref"}, {"key": "ref=102", "unstructured": "Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102(3):814-819", "DOI": "10.1182/blood-2003-01-0091", "doi-asserted-by": "crossref"}, {"key": "ref=103", "unstructured": "Farag SS, Bacigalupo A, Eapen M et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: A report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2006;12(8):876-884", "DOI": "10.1016/j.bbmt.2006.05.007", "doi-asserted-by": "crossref"}, {"key": "ref=104", "unstructured": "Miller JS, Cooley S, Parham P et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood. 2007;109(11):5058-5061", "DOI": "10.1182/blood-2007-01-065383", "doi-asserted-by": "crossref"}, {"key": "ref=105", "unstructured": "Willemze R, Rodrigues CA, Labopin M et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009;23(3):492-500", "DOI": "10.1038/leu.2008.365", "doi-asserted-by": "crossref"}, {"key": "ref=106", "unstructured": "Brunstein CG, Wagner JE, Weisdorf DJ et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood. 2009;113(22):5628-5634", "DOI": "10.1182/blood-2008-12-197467", "doi-asserted-by": "crossref"}, {"key": "ref=107", "unstructured": "Almalte Z, Samarani S, Iannello A et al. Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood. 2011;118(5):1323-1328", "DOI": "10.1182/blood-2010-10-313791", "doi-asserted-by": "crossref"}, {"key": "ref=108", "unstructured": "Pfeiffer M, Schumm M, Feuchtinger T et al. Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia. British Journal of Haematology. 2007;138(1):97-100", "DOI": "10.1111/j.1365-2141.2007.06631.x", "doi-asserted-by": "crossref"}, {"key": "ref=109", "unstructured": "McQueen KL, Dorighi KM, Guethlein LA et al. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Human Immunology. 2007;68(5):309-323", "DOI": "10.1016/j.humimm.2007.01.019", "doi-asserted-by": "crossref"}, {"key": "ref=110", "unstructured": "Stringaris K, Adams S, Uribe M et al. Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 2010;16(9):1257-1264", "DOI": "10.1016/j.bbmt.2010.03.004", "doi-asserted-by": "crossref"}, {"key": "ref=111", "unstructured": "Venstrom JM, Gooley TA, Spellman S et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. 2010;115(15):3162-3165", "DOI": "10.1182/blood-2009-08-236943", "doi-asserted-by": "crossref"}, {"key": "ref=112", "unstructured": "Michaelis SU, Mezger M, Bornhauser M et al. KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Annals of Hematology. 2014;93(9):1579-1586", "DOI": "10.1007/s00277-014-2084-2", "doi-asserted-by": "crossref"}, {"key": "ref=113", "unstructured": "Foley B, De Santis D, Lathbury L et al. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. International Immunology. 2008;20(4):555-563", "DOI": "10.1093/intimm/dxn013", "doi-asserted-by": "crossref"}, {"key": "ref=114", "unstructured": "Venstrom JM, Pittari G, Gooley TA et al. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. The New England Journal of Medicine. 2012;367(9):805-816", "DOI": "10.1056/NEJMoa1200503", "doi-asserted-by": "crossref"}, {"key": "ref=115", "unstructured": "Mancusi A, Ruggeri L, Urbani E et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood. 2015;125(20):3173-3182", "DOI": "10.1182/blood-2014-09-599993", "doi-asserted-by": "crossref"}, {"key": "ref=116", "unstructured": "Cella M, Longo A, Ferrara GB et al. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. The Journal of Experimental Medicine. 1994;180(4):1235-1242", "DOI": "10.1084/jem.180.4.1235", "doi-asserted-by": "crossref"}, {"key": "ref=117", "unstructured": "Draghi M, Yawata N, Gleimer M et al. Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood. 2005;105(5):2028-2035", "DOI": "10.1182/blood-2004-08-3174", "doi-asserted-by": "crossref"}, {"key": "ref=118", "unstructured": "Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics. 2002;31(4):429-434", "DOI": "10.1038/ng934", "doi-asserted-by": "crossref"}, {"key": "ref=119", "unstructured": "Yawata M, Yawata N, Draghi M et al. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood. 2008;112(6):2369-2380", "DOI": "10.1182/blood-2008-03-143727", "doi-asserted-by": "crossref"}, {"key": "ref=120", "unstructured": "Pando MJ, Gardiner CM, Gleimer M et al. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. Journal of Immunology. 2003;171(12):6640-6649", "DOI": "10.4049/jimmunol.171.12.6640", "doi-asserted-by": "crossref"}, {"key": "ref=121", "unstructured": "Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. Journal of Immunology. 2005;175(8):5222-5229", "DOI": "10.4049/jimmunol.175.8.5222", "doi-asserted-by": "crossref"}, {"key": "ref=122", "unstructured": "Moesta AK, Norman PJ, Yawata M et al. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. Journal of Immunology. 2008;180(6):3969-3979", "DOI": "10.4049/jimmunol.180.6.3969", "doi-asserted-by": "crossref"}, {"key": "ref=123", "unstructured": "Ljunggren HG, Karre K. In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition. Immunology Today. 1990;11(7):237-244", "DOI": "10.1016/0167-5699(90)90097-S", "doi-asserted-by": "crossref"}, {"key": "ref=124", "unstructured": "Karre K. Immunology. A perfect mismatch. Science. 2002;295(5562):2029-2031", "DOI": "10.1126/science.1070538", "doi-asserted-by": "crossref"}, {"key": "ref=125", "unstructured": "Leung W, Iyengar R, Triplett B et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. Journal of Immunology. 2005;174(10):6540-6545", "DOI": "10.4049/jimmunol.174.10.6540", "doi-asserted-by": "crossref"}, {"key": "ref=126", "unstructured": "Hsu KC, Gooley T, Malkki M et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2006;12(8):828-836", "DOI": "10.1016/j.bbmt.2006.04.008", "doi-asserted-by": "crossref"}, {"key": "ref=127", "unstructured": "Hsu KC, Keever-Taylor CA, Wilton A et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105(12):4878-4884", "DOI": "10.1182/blood-2004-12-4825", "doi-asserted-by": "crossref"}, {"key": "ref=128", "unstructured": "Leung W, Iyengar R, Turner V et al. Determinants of antileukemia effects of allogeneic NK cells. Journal of Immunology. 2004;172(1):644-650", "DOI": "10.4049/jimmunol.172.1.644", "doi-asserted-by": "crossref"}, {"key": "ref=129", "unstructured": "Ruggeri L, Mancusi A, Capanni M et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging its predictive value. Blood. 2007;110(1):433-440", "DOI": "10.1182/blood-2006-07-038687", "doi-asserted-by": "crossref"}, {"key": "ref=130", "unstructured": "Lonnqvist B, Ringden O, Ljungman P et al. Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection. British Journal of Haematology. 1986;63(4):671-679", "DOI": "10.1111/j.1365-2141.1986.tb07551.x", "doi-asserted-by": "crossref"}, {"key": "ref=131", "unstructured": "Elmaagacli AH, Steckel NK, Koldehoff M et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: Evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011;118(5):1402-1412", "DOI": "10.1182/blood-2010-08-304121", "doi-asserted-by": "crossref"}, {"key": "ref=132", "unstructured": "Green ML, Leisenring WM, Xie H et al. CMV reactivation after allogeneic HCT and relapse risk: Evidence for early protection in acute myeloid leukemia. Blood. 2013;122(7):1316-1324", "DOI": "10.1182/blood-2013-02-487074", "doi-asserted-by": "crossref"}, {"key": "ref=133", "unstructured": "Thomson KJ, Mackinnon S, Peggs KS. CMV-specific cellular therapy for acute myeloid leukemia? Blood. 2012;119(4):1088-1090; author reply 1090-1081", "DOI": "10.1182/blood-2011-10-383943", "doi-asserted-by": "crossref"}, {"key": "ref=134", "unstructured": "Guma M, Budt M, Saez A et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107(9):3624-3631", "DOI": "10.1182/blood-2005-09-3682", "doi-asserted-by": "crossref"}, {"key": "ref=135", "unstructured": "Braud VM, Allan DS, O\u2019Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998;391(6669):795-799", "DOI": "10.1038/35869", "doi-asserted-by": "crossref"}, {"key": "ref=136", "unstructured": "Hosseini E, Schwarer AP, Ghasemzadeh M. Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation? Experimental Hematology 2015;43(3):149-157", "DOI": "10.1016/j.exphem.2014.11.007", "doi-asserted-by": "crossref"}, {"key": "ref=137", "unstructured": "Della Chiesa M, Moretta L, Muccio L et al. Haploidentical haematopoietic stem cell transplantation: Role of NK cells and effect of cytomegalovirus infections. Current Topics in Microbiology and Immunology. 2016;395:209-224", "DOI": "10.1007/82_2015_450", "doi-asserted-by": "crossref"}, {"key": "ref=138", "unstructured": "Foley B, Felices M, Cichocki F et al. The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol Reviews. 2014;258(1):45-63", "DOI": "10.1111/imr.12157", "doi-asserted-by": "crossref"}, {"key": "ref=139", "unstructured": "Della Chiesa M, Falco M, Podesta M et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: A role for human cytomegalovirus? Blood. 2012;119(2):399-410", "DOI": "10.1182/blood-2011-08-372003", "doi-asserted-by": "crossref"}, {"key": "ref=140", "unstructured": "Foley B, Cooley S, Verneris MR et al. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. Journal of Immunology 2012;189(10):5082-5088", "DOI": "10.4049/jimmunol.1201964", "doi-asserted-by": "crossref"}, {"key": "ref=141", "unstructured": "Della Chiesa M, Falco M, Bertaina A et al. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. Journal of Immunology. 2014;192(4):1471-1479", "DOI": "10.4049/jimmunol.1302053", "doi-asserted-by": "crossref"}, {"key": "ref=142", "unstructured": "Di Bona D, Scafidi V, Plaia A et al. HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection. The Journal of Infectious Diseases 2014;210(7):1083-1089", "DOI": "10.1093/infdis/jiu226", "doi-asserted-by": "crossref"}, {"key": "ref=143", "unstructured": "Stern M, Ruggeri L, Mancusi A et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood. 2008;112(7):2990-2995", "DOI": "10.1182/blood-2008-01-135285", "doi-asserted-by": "crossref"}, {"key": "ref=144", "unstructured": "Hwang I, Zhang T, Scott JM et al. Identification of human NK cells that are deficient for signaling adaptor FcRgamma and specialized for antibody-dependent immune functions. International Immunology 2012;24(12):793-802", "DOI": "10.1093/intimm/dxs080", "doi-asserted-by": "crossref"}, {"key": "ref=145", "unstructured": "Lichtfuss GF, Cheng WJ, Farsakoglu Y et al. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. Journal of Immunology. 2012;189(3):1491-1499", "DOI": "10.4049/jimmunol.1200458", "doi-asserted-by": "crossref"}, {"key": "ref=146", "unstructured": "Zhang T, Scott JM, Hwang I, Kim S. Cutting edge: Antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. Journal of Immunology. 2013;190(4):1402-1406", "DOI": "10.4049/jimmunol.1203034", "doi-asserted-by": "crossref"}, {"key": "ref=147", "unstructured": "Guma M, Angulo A, Vilches C et al. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664-3671", "DOI": "10.1182/blood-2004-05-2058", "doi-asserted-by": "crossref"}, {"key": "ref=148", "unstructured": "Cichocki F, Verneris MR, Cooley S et al. The past, present, and future of NK cells in hematopoietic cell transplantation and adoptive transfer. Current topics in Microbiology and Immunology. 2016;395:225-243", "DOI": "10.1007/82_2015_445", "doi-asserted-by": "crossref"}, {"key": "ref=149", "unstructured": "Laffont S, Seillet C, Ortaldo J et al. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood. 2008;112(3):661-671", "DOI": "10.1182/blood-2007-10-120089", "doi-asserted-by": "crossref"}, {"key": "ref=150", "unstructured": "Olson JA, Leveson-Gower DB, Gill S et al. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood. 2010;115(21):4293-4301", "DOI": "10.1182/blood-2009-05-222190", "doi-asserted-by": "crossref"}, {"key": "ref=151", "unstructured": "Lang PA, Lang KS, Xu HC et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(4):1210-1215", "DOI": "10.1073/pnas.1118834109", "doi-asserted-by": "crossref"}, {"key": "ref=152", "unstructured": "Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature. 2011;481(7381):394-398", "DOI": "10.1038/nature10624", "doi-asserted-by": "crossref"}, {"key": "ref=153", "unstructured": "Asai O, Longo DL, Tian ZG et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. The Journal of Clinical Investigation. 1998;101(9):1835-1842", "DOI": "10.1172/JCI1268", "doi-asserted-by": "crossref"}, {"key": "ref=154", "unstructured": "Noval Rivas M, Hazzan M, Weatherly K et al. NK cell regulation of CD4 T cell-mediated graft-versus-host disease. Journal of Immunology. 2010;184(12):6790-6798", "DOI": "10.4049/jimmunol.0902598", "doi-asserted-by": "crossref"}, {"key": "ref=155", "unstructured": "Tsirigotis PD, Resnick IB, Shapira MY. The role of natural killer cells in hematopoietic stem cell transplantation. Annals of Medicine 2012;44(2):130-145", "DOI": "10.3109/07853890.2011.554430", "doi-asserted-by": "crossref"}, {"key": "ref=156", "unstructured": "De Santis D, Bishara A, Witt CS et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens. 2005;65(6):519-528", "DOI": "10.1111/j.1399-0039.2005.00396.x", "doi-asserted-by": "crossref"}, {"key": "ref=157", "unstructured": "Yabe T, Matsuo K, Hirayasu K et al. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2008;14(1):75-87", "DOI": "10.1016/j.bbmt.2007.09.012", "doi-asserted-by": "crossref"}, {"key": "ref=158", "unstructured": "Shah NN, Baird K, Delbrook CP et al. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation. Blood. 2015;125(5):784-792", "DOI": "10.1182/blood-2014-07-592881", "doi-asserted-by": "crossref"}, {"key": "ref=159", "unstructured": "Leung W. Use of NK cell activity in cure by transplant. British Journal of Haematology. 2011;155(1):14-29", "DOI": "10.1111/j.1365-2141.2011.08823.x", "doi-asserted-by": "crossref"}, {"key": "ref=160", "unstructured": "Cooley S, Weisdorf DJ, Guethlein LA et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419", "DOI": "10.1182/blood-2010-05-283051", "doi-asserted-by": "crossref"}, {"key": "ref=161", "unstructured": "Bari R, Bell T, Leung WH et al. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood. 2009;114(25):5182-5190", "DOI": "10.1182/blood-2009-07-231977", "doi-asserted-by": "crossref"}, {"key": "ref=162", "unstructured": "Cartron G, Dacheux L, Salles G et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood. 2002;99(3):754-758", "DOI": "10.1182/blood.V99.3.754", "doi-asserted-by": "crossref"}, {"key": "ref=163", "unstructured": "Miller JS, Soignier Y, Panoskaltsis-Mortari A et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):3051-3057", "DOI": "10.1182/blood-2004-07-2974", "doi-asserted-by": "crossref"}, {"key": "ref=164", "unstructured": "Rubnitz JE, Inaba H, Ribeiro RC et al. NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2010;28(6):955-959", "DOI": "10.1200/JCO.2009.24.4590", "doi-asserted-by": "crossref"}, {"key": "ref=165", "unstructured": "Szmania S, Lapteva N, Garg T et al. Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients. Journal of Immunotherapy. 2015;38(1):24-36", "DOI": "10.1097/CJI.0000000000000059", "doi-asserted-by": "crossref"}, {"key": "ref=166", "unstructured": "Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy. Immunity. 2001;14(2):105-110", "DOI": "10.1016/S1074-7613(09)00091-0", "doi-asserted-by": "crossref"}, {"key": "ref=167", "unstructured": "Rodella L, Zamai L, Rezzani R et al. Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells. British Journal of Haematology. 2001;115(2):442-450", "DOI": "10.1046/j.1365-2141.2001.03055.x", "doi-asserted-by": "crossref"}, {"key": "ref=168", "unstructured": "Denman CJ, Senyukov VV, Somanchi SS et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PloS One. 2012;7(1):e30264", "DOI": "10.1371/journal.pone.0030264", "doi-asserted-by": "crossref"}, {"key": "ref=169", "unstructured": "Somanchi SS, Somanchi A, Cooper LJ, Lee DA. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7. Blood. 2012;119(22):5164-5172", "DOI": "10.1182/blood-2011-11-389924", "doi-asserted-by": "crossref"}, {"key": "ref=170", "unstructured": "Fujisaki H, Kakuda H, Imai C et al. Replicative potential of human natural killer cells. British Journal of Haematology. 2009;145(5):606-613", "DOI": "10.1111/j.1365-2141.2009.07667.x", "doi-asserted-by": "crossref"}, {"key": "ref=171", "unstructured": "Knorr DA, Bachanova V, Verneris MR, Miller JS. Clinical utility of natural killer cells in cancer therapy and transplantation. Seminars in Immunology. 2014;26(2):161-172", "DOI": "10.1016/j.smim.2014.02.002", "doi-asserted-by": "crossref"}, {"key": "ref=172", "unstructured": "Ni J, Miller M, Stojanovic A et al. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. The Journal of Experimental Medicine. 2012;209(13):2351-2365", "DOI": "10.1084/jem.20120944", "doi-asserted-by": "crossref"}, {"key": "ref=173", "unstructured": "Romee R, Rosario M, Berrien-Elliott MM et al. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Science Translational Medicine. 2016;8(357):357ra123", "DOI": "10.1126/scitranslmed.aaf2341", "doi-asserted-by": "crossref"}, {"key": "ref=174", "unstructured": "Skarbnik AP, Faderl S. The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: Current evidence and controversies. Therapeutic Advances in Hematology. 2017;8(3):99-105", "DOI": "10.1177/2040620716681749", "doi-asserted-by": "crossref"}, {"key": "ref=175", "unstructured": "Benson DM, Jr., Bakan CE, Zhang S et al. IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect. Blood. 2011;118(24):6387-6391", "DOI": "10.1182/blood-2011-06-360255", "doi-asserted-by": "crossref"}, {"key": "ref=176", "unstructured": "Romee R, Foley B, Lenvik T et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood. 2013;121(18):3599-3608", "DOI": "10.1182/blood-2012-04-425397", "doi-asserted-by": "crossref"}, {"key": "ref=177", "unstructured": "Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nature Reviews Cancer. 2012;12(4):278-287", "DOI": "10.1038/nrc3236", "doi-asserted-by": "crossref"}, {"key": "ref=178", "unstructured": "Baeuerle PA, Reinhardt C. Bispecific T-cell engaging antibodies for cancer therapy. Cancer Research. 2009;69(12):4941-4944", "DOI": "10.1158/0008-5472.CAN-09-0547", "doi-asserted-by": "crossref"}, {"key": "ref=179", "unstructured": "Bargou R, Leo E, Zugmaier G et al. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science. 2008;321(5891):974-977", "DOI": "10.1126/science.1158545", "doi-asserted-by": "crossref"}, {"key": "ref=180", "unstructured": "Gleason MK, Verneris MR, Todhunter DA et al. Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production. Molecular Cancer Therapeutics. 2012;11(12):2674-2684", "DOI": "10.1158/1535-7163.MCT-12-0692", "doi-asserted-by": "crossref"}, {"key": "ref=181", "unstructured": "Vallera DA, Zhang B, Gleason MK et al. Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells. Cancer Biotherapy &amp; Radiopharmaceuticals. 2013;28(4):274-282", "DOI": "10.1089/cbr.2012.1329", "doi-asserted-by": "crossref"}, {"key": "ref=182", "unstructured": "Wiernik A, Foley B, Zhang B et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2013;19(14):3844-3855", "DOI": "10.1158/1078-0432.CCR-13-0505", "doi-asserted-by": "crossref"}, {"key": "ref=183", "unstructured": "Lundqvist A, Abrams SI, Schrump DS et al. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: A novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Research. 2006;66(14):7317-7325", "DOI": "10.1158/0008-5472.CAN-06-0680", "doi-asserted-by": "crossref"}, {"key": "ref=184", "unstructured": "Wennerberg E, Sarhan D, Carlsten M et al. Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling. International Journal of Cancer Journal International du Cancer. 2013;133(7):1643-1652", "DOI": "10.1002/ijc.28163", "doi-asserted-by": "crossref"}, {"key": "ref=185", "unstructured": "Altvater B, Landmeier S, Pscherer S et al. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2009;15(15):4857-4866", "DOI": "10.1158/1078-0432.CCR-08-2810", "doi-asserted-by": "crossref"}, {"key": "ref=186", "unstructured": "Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood. 2005;106(1):376-383", "DOI": "10.1182/blood-2004-12-4797", "doi-asserted-by": "crossref"}, {"key": "ref=187", "unstructured": "Arai S, Meagher R, Swearingen M et al. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: A phase I trial. Cytotherapy. 2008;10(6):625-632", "DOI": "10.1080/14653240802301872", "doi-asserted-by": "crossref"}], "container-title": ["Natural Killer Cells"], "link": [{"URL": "http://www.intechopen.com/download/pdf/55987", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 7]], "date-time": "2019-10-07T23:48:45Z", "timestamp": 1570492125000}, "score": 28.590971, "issued": {"date-parts": [[2017, 12, 13]]}, "ISBN": ["9789535136712", "9789535136729"], "references-count": 187, "URL": "http://dx.doi.org/10.5772/intechopen.69684", "relation": {"cites": []}}, {"institution": {"name": "Iowa State University, Digital Repository", "place": ["Ames"], "department": ["Food Science and Human Nutrition"], "acronym": ["ISU"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:31:02Z", "timestamp": 1574865062063}, "reference-count": 0, "publisher": "Iowa State University", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.31274/rtd-180817-2288", "type": "dissertation", "created": {"date-parts": [[2018, 8, 13]], "date-time": "2018-08-13T23:12:17Z", "timestamp": 1534201937000}, "approved": {"date-parts": [[2001]]}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Role and modulation factors of liver-associated natural killer cell during fumonisin B1 hepatocarcinogenesis in rats"], "prefix": "10.31274", "author": [{"given": "Hongjun", "family": "Liu", "sequence": "first", "affiliation": [{"name": "Iowa State University"}]}], "member": "13687", "deposited": {"date-parts": [[2018, 8, 13]], "date-time": "2018-08-13T23:30:48Z", "timestamp": 1534203048000}, "score": 26.154808, "degree": ["Doctor of Philosophy"], "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.31274/rtd-180817-2288"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T01:13:52Z", "timestamp": 1574817232440}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 7, 1]]}, "DOI": "10.1158/1538-7445.am2017-3769", "type": "proceedings-article", "created": {"date-parts": [[2017, 7, 31]], "date-time": "2017-07-31T21:43:48Z", "timestamp": 1501537428000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 3769: Stem cell-engineered invariant natural killer T cells for cancer therapy"], "prefix": "10.1158", "author": [{"given": "Lili", "family": "Yang", "sequence": "first", "affiliation": []}, {"given": "Drake", "family": "Smith", "sequence": "additional", "affiliation": []}, {"given": "Siyuan", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Sunjong", "family": "Ji", "sequence": "additional", "affiliation": []}, {"given": "Bo", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2017, 7, 2]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC"}, "container-title": ["Immunology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2017-3769", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T18:14:40Z", "timestamp": 1558203280000}, "score": 23.619072, "issued": {"date-parts": [[2017, 7, 1]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2017-3769"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2017-3769"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:00:16Z", "timestamp": 1574445616760}, "publisher-location": "Basel", "reference-count": 0, "publisher": "KARGER", "isbn-type": [{"value": "9783805563321", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996]]}, "DOI": "10.1159/000319341", "type": "book-chapter", "created": {"date-parts": [[2010, 7, 16]], "date-time": "2010-07-16T07:59:28Z", "timestamp": 1279267168000}, "page": "164-180", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Allorecognition by Murine Natural Killer Cells: Studies with Bone Marrow Transplants and Lysis of T Lymphoblasts"], "prefix": "10.1159", "author": [{"given": "Jingxuan", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Yik Yeung Lawrence", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "Kirsten Fischer", "family": "Lindahl", "sequence": "additional", "affiliation": []}, {"given": "Vinay", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Molecular Basis of NK Cell Recognition and Function", "Chemical Immunology and Allergy"], "link": [{"URL": "http://www.karger.com/Article/Pdf/319341", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T18:52:25Z", "timestamp": 1508957545000}, "score": 23.219185, "issued": {"date-parts": [[1996]]}, "ISBN": ["9783805563321"], "references-count": 0, "URL": "http://dx.doi.org/10.1159/000319341", "ISSN": ["1660-2242"], "issn-type": [{"value": "1660-2242", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:12:13Z", "timestamp": 1574691133482}, "reference-count": 0, "publisher": "S. Karger AG", "isbn-type": [{"value": "9783805563321", "type": "print"}, {"value": "9783318015515", "type": "electronic"}], "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1159/000425594", "type": "book-chapter", "created": {"date-parts": [[2015, 4, 16]], "date-time": "2015-04-16T14:57:11Z", "timestamp": 1429196231000}, "page": "164-180", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Allorecognition by Murine Natural Killer Cells: Studies with Bone Marrow Transplants and Lysis of T Lymphoblasts"], "prefix": "10.1159", "author": [{"given": "Jingxuan", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Yik Yeung Lawrence", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "Kirsten Fischer", "family": "Lindahl", "sequence": "additional", "affiliation": []}, {"given": "Vinay", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Molecular Basis of NK Cell Recognition and Function", "Chemical Immunology and Allergy"], "link": [{"URL": "https://www.karger.com/Article/Pdf/425594", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.karger.com/Article/Pdf/425594", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 22]], "date-time": "2018-08-22T14:49:26Z", "timestamp": 1534949366000}, "score": 23.219185, "issued": {"date-parts": [[null]]}, "ISBN": ["9783805563321", "9783318015515"], "references-count": 0, "alternative-id": ["000425594"], "URL": "http://dx.doi.org/10.1159/000425594", "ISSN": ["1660-2242", "1662-2898"], "issn-type": [{"value": "1660-2242", "type": "print"}, {"value": "1662-2898", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T09:54:31Z", "timestamp": 1575453271438}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 3, 1]], "date-time": "2014-03-01T00:00:00Z", "timestamp": 1393632000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chest"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1378/chest.1835194", "type": "journal-article", "created": {"date-parts": [[2014, 3, 18]], "date-time": "2014-03-18T07:32:35Z", "timestamp": 1395127955000}, "page": "114A", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Novel Case of Hyper IgE Syndrome Combined With Natural Killer Cell Deficiency"], "prefix": "10.1016", "volume": "145", "author": [{"given": "Xiaolei", "family": "Zhang", "sequence": "first", "affiliation": []}, {"given": "Huaping", "family": "Dai", "sequence": "additional", "affiliation": []}, {"given": "Yan", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Chest"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0012369216458204?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0012369216458204?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 6]], "date-time": "2018-10-06T01:27:03Z", "timestamp": 1538789223000}, "score": 22.701452, "issued": {"date-parts": [[2014, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 3]]}, "issue": "3"}, "alternative-id": ["S0012369216458204"], "URL": "http://dx.doi.org/10.1378/chest.1835194", "ISSN": ["0012-3692"], "issn-type": [{"value": "0012-3692", "type": "print"}], "subject": ["Critical Care and Intensive Care Medicine", "Pulmonary and Respiratory Medicine", "Cardiology and Cardiovascular Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T12:21:22Z", "timestamp": 1574857282826}, "reference-count": 46, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "lrjournal.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2018, 1]]}, "DOI": "10.1016/j.leukres.2017.11.001", "type": "journal-article", "created": {"date-parts": [[2017, 11, 11]], "date-time": "2017-11-11T06:30:41Z", "timestamp": 1510381841000}, "page": "1-9", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma"], "prefix": "10.1016", "volume": "64", "author": [{"given": "Pingyi", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Lingling", "family": "Chen", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212617305714?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212617305714?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 6]], "date-time": "2019-10-06T01:12:54Z", "timestamp": 1570324374000}, "score": 22.444641, "issued": {"date-parts": [[2018, 1]]}, "references-count": 46, "alternative-id": ["S0145212617305714"], "URL": "http://dx.doi.org/10.1016/j.leukres.2017.11.001", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma", "name": "articletitle", "label": "Article Title"}, {"value": "Leukemia Research", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.leukres.2017.11.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T18:39:36Z", "timestamp": 1575484776593}, "reference-count": 145, "publisher": "MDPI AG", "issue": "7", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2019, 7, 23]], "date-time": "2019-07-23T00:00:00Z", "timestamp": 1563840000000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/501100002794", "name": "Cancerfonden", "doi-asserted-by": "publisher", "award": ["CAN 2018/451"]}, {"DOI": "10.13039/501100006313", "name": "Barncancerfonden", "doi-asserted-by": "publisher", "award": ["PR2017-0049"]}, {"DOI": "10.13039/501100007232", "name": "Radiumhemmets Forskningsfonder", "doi-asserted-by": "publisher", "award": ["181183"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancers"], "abstract": "<jats:p>The immune system plays a crucial role to prevent local growth and dissemination of cancer. Therapies based on activating the immune system can result in beneficial responses in patients with metastatic disease. Treatment with antibodies targeting the immunological checkpoint axis PD-1 / PD-L1 can result in the induction of anti-tumor T cell activation leading to meaningful long-lasting clinical responses. Still, many patients acquire resistance or develop dose-limiting toxicities to these therapies. Analysis of tumors from patients who progress on anti-PD-1 treatment reveal defective interferon-signaling and antigen presentation, resulting in immune escape from T cell-mediated attack. Natural killer (NK) cells are innate lymphocytes that can kill tumor cells without prior sensitization to antigens and can be activated to kill tumor cells that have an impaired antigen processing and presentation machinery. Thus, NK cells may serve as useful effectors against tumor cells that have become resistant to classical immune checkpoint therapy. Various approaches to activate NK cells are being increasingly explored in clinical trials against cancer. While clinical benefit has been demonstrated in patients with acute myeloid leukemia receiving haploidentical NK cells, responses in patients with solid tumors are so far less encouraging. Several hurdles need to be overcome to provide meaningful clinical responses in patients with solid tumors. Here we review the recent developments to augment NK cell responses against solid tumors with regards to cytokine therapy, adoptive infusion of NK cells, NK cell engagers, and NK cell immune checkpoints.</jats:p>", "DOI": "10.3390/cancers11071040", "type": "journal-article", "created": {"date-parts": [[2019, 7, 24]], "date-time": "2019-07-24T14:48:19Z", "timestamp": 1563979699000}, "page": "1040", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors"], "prefix": "10.3390", "volume": "11", "author": [{"given": "Ziqing", "family": "Chen", "sequence": "first", "affiliation": []}, {"given": "Ying", "family": "Yang", "sequence": "additional", "affiliation": []}, {"given": "Lisa L.", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Andreas", "family": "Lundqvist", "sequence": "additional", "affiliation": []}], "member": "1968", "published-online": {"date-parts": [[2019, 7, 23]]}, "reference": [{"key": "ref1", "DOI": "10.4161/21624011.2014.955684", "doi-asserted-by": "publisher"}, {"key": "ref2", "DOI": "10.1038/nrclinonc.2014.111", "doi-asserted-by": "publisher"}, {"key": "ref3", "DOI": "10.1038/nri3191", "doi-asserted-by": "publisher"}, {"key": "ref4", "DOI": "10.1038/nri3174", "doi-asserted-by": "publisher"}, {"key": "ref5", "DOI": "10.1002/ijc.2910160205", "doi-asserted-by": "publisher"}, {"key": "ref6", "DOI": "10.1002/eji.1830050208", "doi-asserted-by": "publisher"}, {"key": "ref7", "DOI": "10.1126/science.1068440", "doi-asserted-by": "publisher"}, {"key": "ref8", "DOI": "10.1126/science.1070538", "doi-asserted-by": "publisher"}, {"key": "ref9", "DOI": "10.3389/fimmu.2015.00202", "doi-asserted-by": "publisher"}, {"key": "ref10", "DOI": "10.1158/0008-5472.CAN-13-0371", "doi-asserted-by": "publisher"}, {"key": "ref11", "DOI": "10.1158/0008-5472.CAN-11-0792", "doi-asserted-by": "publisher"}, {"key": "ref12", "DOI": "10.1002/eji.201344272", "doi-asserted-by": "publisher"}, {"key": "ref13", "DOI": "10.1038/nri2580", "doi-asserted-by": "publisher"}, {"key": "ref14", "DOI": "10.1038/sj.bmt.1704086", "doi-asserted-by": "publisher"}, {"key": "ref15", "DOI": "10.4049/jimmunol.1490019", "doi-asserted-by": "publisher"}, {"key": "ref16", "DOI": "10.1038/bjc.1991.67", "doi-asserted-by": "publisher"}, {"key": "ref17", "DOI": "10.1084/jem.20051511", "doi-asserted-by": "publisher"}, {"key": "ref18", "DOI": "10.1038/nature10975", "doi-asserted-by": "publisher"}, {"key": "ref19", "DOI": "10.1038/s41586-018-0830-7", "doi-asserted-by": "publisher"}, {"key": "ref20", "DOI": "10.1158/1078-0432.CCR-15-1631", "doi-asserted-by": "publisher"}, {"key": "ref21", "DOI": "10.1158/2159-8290.CD-18-1495", "doi-asserted-by": "publisher"}, {"key": "ref22", "DOI": "10.4049/jimmunol.170.10.5018", "doi-asserted-by": "publisher"}, {"key": "ref23", "DOI": "10.1200/JCO.2014.57.3329", "doi-asserted-by": "publisher"}, {"key": "ref24", "DOI": "10.1158/2326-6066.CIR-15-0009", "doi-asserted-by": "publisher"}, {"key": "ref25", "DOI": "10.3389/fimmu.2015.00355", "doi-asserted-by": "publisher"}, {"key": "ref26", "DOI": "10.1182/blood-2016-02-698027", "doi-asserted-by": "publisher"}, {"key": "ref27", "DOI": "10.1126/scisignal.aad1884", "doi-asserted-by": "publisher"}, {"key": "ref28", "DOI": "10.1172/jci.insight.96219", "doi-asserted-by": "publisher"}, {"key": "ref29", "DOI": "10.1158/1078-0432.CCR-18-3468", "doi-asserted-by": "publisher"}, {"key": "ref30", "DOI": "10.1158/2326-6066.CIR-15-0093-T", "doi-asserted-by": "publisher"}, {"key": "ref31", "DOI": "10.1182/blood-2017-12-823757", "doi-asserted-by": "publisher"}, {"key": "ref32", "DOI": "10.1016/j.drudis.2012.01.007", "doi-asserted-by": "publisher"}, {"key": "ref33", "DOI": "10.1002/ijc.28059", "doi-asserted-by": "publisher"}, {"key": "ref34", "DOI": "10.1080/2162402X.2018.1532764", "doi-asserted-by": "publisher"}, {"key": "ref35", "DOI": "10.1016/S1470-2045(18)30148-7", "doi-asserted-by": "publisher"}, {"key": "ref36", "DOI": "10.1038/ncomms15776", "doi-asserted-by": "publisher"}, {"key": "ref37", "DOI": "10.1016/j.molimm.2017.06.025", "doi-asserted-by": "publisher"}, {"key": "ref38", "DOI": "10.1080/2162402X.2016.1274478", "doi-asserted-by": "publisher"}, {"key": "ref39", "DOI": "10.1182/blood-2012-04-419283", "doi-asserted-by": "publisher"}, {"key": "ref40", "DOI": "10.1182/blood-2013-10-532531", "doi-asserted-by": "publisher"}, {"key": "ref41", "DOI": "10.1158/1078-0432.CCR-17-3196", "doi-asserted-by": "publisher"}, {"key": "ref42", "DOI": "10.1182/blood-2011-01-329508", "doi-asserted-by": "publisher"}, {"key": "ref43", "DOI": "10.1182/blood-2004-07-2974", "doi-asserted-by": "publisher"}, {"key": "ref44", "DOI": "10.1056/NEJM198512053132327", "doi-asserted-by": "publisher"}, {"key": "ref45", "DOI": "10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N", "doi-asserted-by": "publisher"}, {"key": "ref46", "DOI": "10.1158/1078-0432.CCR-11-1347", "doi-asserted-by": "publisher"}, {"key": "ref47", "DOI": "10.1002/ijc.31285", "doi-asserted-by": "publisher"}, {"key": "ref48", "DOI": "10.1016/j.bbmt.2017.07.011", "doi-asserted-by": "publisher"}, {"key": "ref49", "DOI": "10.1007/s00262-010-0904-3", "doi-asserted-by": "publisher"}, {"key": "ref50", "DOI": "10.3109/14653249.2010.515582", "doi-asserted-by": "publisher"}, {"key": "ref51", "DOI": "10.1158/2326-6066.CIR-15-0118", "doi-asserted-by": "publisher"}, {"key": "ref52", "DOI": "10.3389/fimmu.2018.02517", "doi-asserted-by": "publisher"}, {"key": "ref53", "DOI": "10.3389/fimmu.2015.00482", "doi-asserted-by": "publisher"}, {"key": "ref54", "DOI": "10.1158/1078-0432.CCR-14-0635", "doi-asserted-by": "publisher"}, {"key": "ref55", "DOI": "10.1158/0008-5472.CAN-16-0839", "doi-asserted-by": "publisher"}, {"key": "ref56", "DOI": "10.1158/2326-6066.CIR-17-0498", "doi-asserted-by": "publisher"}, {"key": "ref57", "DOI": "10.1038/nature03847", "doi-asserted-by": "publisher"}, {"key": "ref58", "DOI": "10.1007/s00262-014-1629-5", "doi-asserted-by": "publisher"}, {"key": "ref59", "DOI": "10.3389/fimmu.2018.02159", "doi-asserted-by": "publisher"}, {"key": "ref60", "DOI": "10.1186/s40425-017-0275-9", "doi-asserted-by": "publisher"}, {"key": "ref61", "DOI": "10.1158/2326-6066.CIR-14-0114", "doi-asserted-by": "publisher"}, {"key": "ref62", "DOI": "10.1038/cgt.2009.61", "doi-asserted-by": "publisher"}, {"key": "ref63", "DOI": "10.3109/14653249.2012.671519", "doi-asserted-by": "publisher"}, {"key": "ref64", "DOI": "10.1038/leu.2017.226", "doi-asserted-by": "publisher"}, {"key": "ref65", "DOI": "10.1016/j.ebiom.2019.01.031", "doi-asserted-by": "publisher"}, {"key": "ref66", "DOI": "10.1002/eji.201948140", "doi-asserted-by": "publisher"}, {"key": "ref67", "DOI": "10.4049/jimmunol.180.1.163", "doi-asserted-by": "publisher"}, {"key": "ref68", "DOI": "10.1158/0008-5472.CAN-06-0680", "doi-asserted-by": "publisher"}, {"key": "ref69", "DOI": "10.1007/s00262-013-1439-1", "doi-asserted-by": "publisher"}, {"key": "ref70", "DOI": "10.1158/0008-5472.CAN-05-0599", "doi-asserted-by": "publisher"}, {"key": "ref71", "DOI": "10.1002/ijc.28163", "doi-asserted-by": "publisher"}, {"key": "ref72", "DOI": "10.1182/blood-2008-11-190421", "doi-asserted-by": "publisher"}, {"key": "ref73", "DOI": "10.7150/jca.2.383", "doi-asserted-by": "publisher"}, {"key": "ref74", "DOI": "10.1016/j.virol.2017.06.033", "doi-asserted-by": "publisher"}, {"key": "ref75", "DOI": "10.1186/1471-2407-14-370", "doi-asserted-by": "publisher"}, {"key": "ref76", "DOI": "10.1016/j.canlet.2008.06.027", "doi-asserted-by": "publisher"}, {"key": "ref77", "DOI": "10.1158/0008-5472.CAN-04-4252", "doi-asserted-by": "publisher"}, {"key": "ref78", "DOI": "10.1016/j.stem.2018.06.002", "doi-asserted-by": "publisher"}, {"key": "ref79", "DOI": "10.1093/glycob/5.8.813", "doi-asserted-by": "publisher"}, {"key": "ref80", "DOI": "10.1038/6179", "doi-asserted-by": "publisher"}, {"key": "ref81", "DOI": "10.1097/01.cji.0000175684.28615.7b", "doi-asserted-by": "publisher"}, {"key": "ref82", "DOI": "10.1002/bit.1119", "doi-asserted-by": "publisher"}, {"key": "ref83", "DOI": "10.1073/pnas.0508123103", "doi-asserted-by": "publisher"}, {"key": "ref84", "DOI": "10.1038/leu.2016.194", "doi-asserted-by": "publisher"}, {"key": "ref85", "DOI": "10.1182/blood-2014-04-569061", "doi-asserted-by": "publisher"}, {"key": "ref86", "DOI": "10.3109/10428199809059232", "doi-asserted-by": "publisher"}, {"key": "ref87", "DOI": "10.1111/j.1365-2141.2004.04893.x", "doi-asserted-by": "publisher"}, {"key": "ref88", "DOI": "10.1016/j.canlet.2011.01.020", "doi-asserted-by": "publisher"}, {"key": "ref89", "DOI": "10.1038/mt.2013.14", "doi-asserted-by": "publisher"}, {"key": "ref90", "DOI": "10.1111/j.1742-4658.2011.08417.x", "doi-asserted-by": "publisher"}, {"key": "ref91", "DOI": "10.1016/j.bbrc.2003.09.211", "doi-asserted-by": "publisher"}, {"key": "ref92", "DOI": "10.1182/blood-2013-10-533398", "doi-asserted-by": "publisher"}, {"key": "ref93", "DOI": "10.1158/1078-0432.CCR-13-0505", "doi-asserted-by": "publisher"}, {"key": "ref94", "DOI": "10.1038/mt.2016.88", "doi-asserted-by": "publisher"}, {"key": "ref95", "DOI": "10.1158/2326-6066.CIR-17-0649", "doi-asserted-by": "publisher"}, {"key": "ref96", "DOI": "10.4049/jimmunol.1402517", "doi-asserted-by": "publisher"}, {"key": "ref97", "DOI": "10.1097/CJI.0000000000000215", "doi-asserted-by": "publisher"}, {"key": "ref98", "DOI": "10.1002/ijc.28609", "doi-asserted-by": "publisher"}, {"key": "ref99", "DOI": "10.1182/blood-2005-05-2177", "doi-asserted-by": "publisher"}, {"key": "ref100", "DOI": "10.1093/protein/gzx043", "doi-asserted-by": "publisher"}, {"key": "ref101", "DOI": "10.1016/j.cell.2019.04.041", "doi-asserted-by": "publisher"}, {"key": "ref102", "DOI": "10.1158/1078-0432.CCR-15-2710", "doi-asserted-by": "publisher"}, {"key": "ref103", "DOI": "10.1182/bloodadvances.2017012369", "doi-asserted-by": "publisher"}, {"key": "ref104", "DOI": "10.1038/s41577-018-0061-z", "doi-asserted-by": "publisher"}, {"key": "ref105", "DOI": "10.1038/nrc.2015.5", "doi-asserted-by": "publisher"}, {"key": "ref106", "DOI": "10.1182/blood-2009-02-206532", "doi-asserted-by": "publisher"}, {"key": "ref107", "DOI": "10.1182/blood-2011-06-360255", "doi-asserted-by": "publisher"}, {"key": "ref108", "DOI": "10.1182/blood-2013-08-519199", "doi-asserted-by": "publisher"}, {"key": "ref109", "DOI": "10.1182/blood-2012-06-437558", "doi-asserted-by": "publisher"}, {"key": "ref110", "DOI": "10.1182/blood-2012-06-438028", "doi-asserted-by": "publisher"}, {"key": "ref111", "DOI": "10.1073/pnas.0901653106", "doi-asserted-by": "publisher"}, {"key": "ref112", "DOI": "10.3324/haematol.2013.103085", "doi-asserted-by": "publisher"}, {"key": "ref113", "DOI": "10.1158/1078-0432.CCR-16-1108", "doi-asserted-by": "publisher"}, {"key": "ref114", "DOI": "10.18632/oncotarget.24832", "doi-asserted-by": "publisher"}, {"key": "ref115", "DOI": "10.3324/haematol.2014.117531", "doi-asserted-by": "publisher"}, {"key": "ref116", "DOI": "10.1016/j.molimm.2004.07.031", "doi-asserted-by": "publisher"}, {"key": "ref117", "DOI": "10.3892/ol.2017.5891", "doi-asserted-by": "publisher"}, {"key": "ref118", "DOI": "10.3324/haematol.2015.135301", "doi-asserted-by": "publisher"}, {"key": "ref119", "DOI": "10.1016/j.cell.2018.10.028", "doi-asserted-by": "publisher"}, {"key": "ref120", "DOI": "10.1007/s00109-008-0417-0", "doi-asserted-by": "publisher"}, {"key": "ref121", "author": "Furutani", "year": "2010", "series-title": "siRNA Inactivation of the Inhibitory Receptor NKG2A Augments the Anti-Tumor Effects of Adoptively Transferred NK Cells in Tumor-Bearing Hosts"}, {"key": "ref122", "DOI": "10.1172/JCI123955", "doi-asserted-by": "publisher"}, {"key": "ref123", "DOI": "10.1080/2162402X.2016.1226720", "doi-asserted-by": "publisher"}, {"key": "ref124", "DOI": "10.1002/JLB.MR0718-300R", "doi-asserted-by": "publisher"}, {"key": "ref125", "DOI": "10.1016/j.cell.2018.10.014", "doi-asserted-by": "publisher"}, {"key": "ref126", "DOI": "10.1016/j.semcancer.2006.07.002", "doi-asserted-by": "publisher"}, {"key": "ref127", "DOI": "10.1038/ni.2850", "doi-asserted-by": "publisher"}, {"key": "ref128", "DOI": "10.1158/1078-0432.CCR-16-0933", "doi-asserted-by": "publisher"}, {"key": "ref129", "DOI": "10.1038/ni.3470", "doi-asserted-by": "publisher"}, {"key": "ref130", "DOI": "10.1080/2162402X.2016.1267892", "doi-asserted-by": "publisher"}, {"key": "ref131", "DOI": "10.1016/j.immuni.2013.11.010", "doi-asserted-by": "publisher"}, {"key": "ref132", "DOI": "10.1038/nature24293", "doi-asserted-by": "publisher"}, {"key": "ref133", "DOI": "10.1016/j.jaci.2016.04.025", "doi-asserted-by": "publisher"}, {"key": "ref134", "DOI": "10.1056/NEJMoa1801946", "doi-asserted-by": "publisher"}, {"key": "ref135", "DOI": "10.1056/NEJMoa1712126", "doi-asserted-by": "publisher"}, {"key": "ref136", "DOI": "10.1056/NEJMoa1302369", "doi-asserted-by": "publisher"}, {"key": "ref137", "DOI": "10.1182/blood-2010-02-271874", "doi-asserted-by": "publisher"}, {"key": "ref138", "DOI": "10.3892/or.2015.4149", "doi-asserted-by": "publisher"}, {"key": "ref139", "DOI": "10.3109/08820139.2015.1052145", "doi-asserted-by": "publisher"}, {"key": "ref140", "DOI": "10.1158/2326-6066.CIR-13-0171", "doi-asserted-by": "publisher"}, {"key": "ref141", "DOI": "10.1016/j.intimp.2015.09.017", "doi-asserted-by": "publisher"}, {"key": "ref142", "DOI": "10.1002/eji.201344413", "doi-asserted-by": "publisher"}, {"key": "ref143", "author": "Lee", "year": "2019", "series-title": "Abstract A085: High Infiltration of NK Cells Expressing Elevated LAG-3 in A Subgroup of Renal Cell Carcinoma Patients"}, {"key": "ref144", "DOI": "10.1111/imr.12519", "doi-asserted-by": "publisher"}, {"key": "ref145", "DOI": "10.18632/genesandcancer.180", "doi-asserted-by": "publisher"}], "container-title": ["Cancers"], "language": "en", "link": [{"URL": "https://www.mdpi.com/2072-6694/11/7/1040/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 22]], "date-time": "2019-09-22T15:40:09Z", "timestamp": 1569166809000}, "score": 22.091301, "issued": {"date-parts": [[2019, 7, 23]]}, "references-count": 145, "journal-issue": {"published-online": {"date-parts": [[2019, 7]]}, "issue": "7"}, "alternative-id": ["cancers11071040"], "URL": "http://dx.doi.org/10.3390/cancers11071040", "relation": {"cites": []}, "ISSN": ["2072-6694"], "issn-type": [{"value": "2072-6694", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:53:33Z", "timestamp": 1574510013896}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 5, 1]], "date-time": "2011-05-01T00:00:00Z", "timestamp": 1304208000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical and Biophysical Research Communications"], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1016/j.bbrc.2011.04.102", "type": "journal-article", "created": {"date-parts": [[2011, 4, 30]], "date-time": "2011-04-30T21:32:13Z", "timestamp": 1304199133000}, "page": "40-45", "source": "Crossref", "is-referenced-by-count": 7, "title": ["The influence of natural mineral water on aquaporin water permeability and human natural killer cell activity"], "prefix": "10.1016", "volume": "409", "author": [{"given": "Yoshichika", "family": "Kitagawa", "sequence": "first", "affiliation": []}, {"given": "Chengwei", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Xiaodong", "family": "Ding", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical and Biophysical Research Communications"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006291X11007005?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006291X11007005?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 3]], "date-time": "2018-12-03T04:27:14Z", "timestamp": 1543811234000}, "score": 22.022415, "issued": {"date-parts": [[2011, 5]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "1"}, "alternative-id": ["S0006291X11007005"], "URL": "http://dx.doi.org/10.1016/j.bbrc.2011.04.102", "ISSN": ["0006-291X"], "issn-type": [{"value": "0006-291X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:33:17Z", "timestamp": 1575109997969}, "reference-count": 13, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transplantation"], "published-print": {"date-parts": [[2002, 11]]}, "DOI": "10.1097/00007890-200211270-00018", "type": "journal-article", "created": {"date-parts": [[2003, 12, 2]], "date-time": "2003-12-02T11:34:14Z", "timestamp": 1070364854000}, "page": "1449-1454", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Definition Of Additional Functional Ligands For Ly49IB6 Using FVBLy49IB6 Transgenic Mice And B6 Natural Killer Cell Effectors1"], "prefix": "10.1097", "volume": "74", "author": [{"given": "Margaret A.", "family": "Morris", "sequence": "first", "affiliation": []}, {"given": "Elena", "family": "Koulich", "sequence": "additional", "affiliation": []}, {"given": "Jingxuan", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Veera", "family": "Arora", "sequence": "additional", "affiliation": []}, {"given": "Thaddeus C.", "family": "George", "sequence": "additional", "affiliation": []}, {"given": "John D.", "family": "Schatzle", "sequence": "additional", "affiliation": []}, {"given": "Vinay", "family": "Kumar", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bennett", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Transplantation"], "language": "en", "deposited": {"date-parts": [[2018, 3, 27]], "date-time": "2018-03-27T03:21:03Z", "timestamp": 1522120863000}, "score": 21.596657, "subtitle": [""], "issued": {"date-parts": [[2002, 11]]}, "references-count": 13, "journal-issue": {"issue": "10"}, "URL": "http://dx.doi.org/10.1097/00007890-200211270-00018", "ISSN": ["0041-1337"], "issn-type": [{"value": "0041-1337", "type": "print"}], "subject": ["Transplantation"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:30:23Z", "timestamp": 1574112623226}, "reference-count": 0, "publisher": "Microbiology Society", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of General Virology"], "published-print": {"date-parts": [[2004, 2, 1]]}, "DOI": "10.1099/vir.0.19596-0", "type": "journal-article", "created": {"date-parts": [[2004, 2, 9]], "date-time": "2004-02-09T22:07:58Z", "timestamp": 1076364478000}, "page": "423-428", "source": "Crossref", "is-referenced-by-count": 77, "title": ["Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity"], "prefix": "10.1099", "volume": "85", "author": [{"given": "B.", "family": "Liu", "sequence": "first", "affiliation": []}], "member": "345", "container-title": ["Journal of General Virology"], "language": "en", "deposited": {"date-parts": [[2019, 8, 12]], "date-time": "2019-08-12T15:25:38Z", "timestamp": 1565623538000}, "score": 21.42456, "issued": {"date-parts": [[2004, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1099/vir.0.19596-0", "ISSN": ["0022-1317", "1465-2099"], "issn-type": [{"value": "0022-1317", "type": "print"}, {"value": "1465-2099", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:12:52Z", "timestamp": 1574525572819}, "reference-count": 100, "publisher": "Informa UK Limited", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2011, 12]]}, "DOI": "10.3109/10428194.2011.593276", "type": "journal-article", "created": {"date-parts": [[2011, 7, 13]], "date-time": "2011-07-13T14:58:36Z", "timestamp": 1310569116000}, "page": "2217-2225", "source": "Crossref", "is-referenced-by-count": 26, "title": ["T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias"], "prefix": "10.1080", "volume": "52", "author": [{"given": "Rebecca J.", "family": "Watters", "sequence": "first", "affiliation": []}, {"given": "Xin", "family": "Liu", "sequence": "additional", "affiliation": []}, {"suffix": "Jr", "given": "Thomas P.", "family": "Loughran", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2011, 7, 13]]}, "reference": [{"key": "CIT0001", "author": "Alekshun TJ", "volume": "14", "first-page": "141", "year": "2007", "journal-title": "Cancer Control", "DOI": "10.1177/107327480701400207", "doi-asserted-by": "crossref"}, {"key": "CIT0002", "author": "Zhang R", "volume": "28", "first-page": "105", "year": "2010", "journal-title": "Hematol Oncol"}, {"key": "CIT0003", "DOI": "10.1634/theoncologist.11-3-263", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1146/annurev.immunol.25.022106.141548", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.7326/0003-4819-102-2-169", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1136/jcp.42.6.567", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Loughran TP", "volume": "82", "first-page": "1", "year": "1993", "journal-title": "Blood"}, {"key": "CIT0008", "author": "Loughran TP", "volume": "84", "first-page": "2164", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0009", "author": "Harris NL", "volume": "17", "first-page": "3835", "year": "1999", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1999.17.12.3835", "doi-asserted-by": "crossref"}, {"key": "CIT0010", "DOI": "10.1182/blood-2010-07-296962", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1038/35037728", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.3816/CLM.2009.s.019", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "author": "Smyth MJ", "volume": "70", "first-page": "18", "year": "2001", "journal-title": "J Leukoc Biol"}, {"key": "CIT0014", "DOI": "10.1634/theoncologist.9-3-247", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "author": "Freimark B", "volume": "138", "first-page": "1724", "year": "1987", "journal-title": "J Immunol"}, {"key": "CIT0016", "DOI": "10.1002/art.1780400406", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1002/art.1780370909", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1097/MOH.0b013e32834760fb", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1002/art.1780310105", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "author": "Dhodapkar MV", "volume": "84", "first-page": "1620", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0021", "DOI": "10.3109/10428199609054846", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1681/ASN.2007111225", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.4049/jimmunol.172.3.1960", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1136/mp.50.2.77", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1309/835B04QXGNNFNRJU", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1182/blood.V99.1.268", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/S0037-1963(03)00135-5", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "author": "Loughran TP", "volume": "80", "first-page": "1116", "year": "1992", "journal-title": "Blood"}, {"key": "CIT0029", "author": "Oshimi K", "volume": "7", "first-page": "782", "year": "1993", "journal-title": "Leukemia"}, {"key": "CIT0030", "DOI": "10.1046/j.0007-1048.2001.03315.x", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "author": "Parkman R", "volume": "2", "first-page": "253", "year": "1991", "journal-title": "Immunodefic Rev"}, {"key": "CIT0032", "DOI": "10.1517/14656566.3.7.845", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1016/0049-0172(83)90014-8", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.1016/j.berh.2004.05.002", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1097/00002281-200405000-00008", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1016/S0037-1963(03)00133-1", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "author": "Schweitzer BI", "volume": "4", "first-page": "2441", "year": "1990", "journal-title": "FASEB J", "DOI": "10.1096/fasebj.4.8.2185970", "doi-asserted-by": "crossref"}, {"key": "CIT0038", "DOI": "10.1006/abbi.1998.0703", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1136/ard.62.1.4", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1002/anr.1780320616", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "author": "McKendry RJ", "volume": "20", "first-page": "1850", "year": "1993", "journal-title": "J Rheumatol"}, {"key": "CIT0042", "DOI": "10.1016/S0889-857X(05)70365-3", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "author": "Hooijberg JH", "volume": "59", "first-page": "2532", "year": "1999", "journal-title": "Cancer Res"}, {"key": "CIT0044", "DOI": "10.1046/j.1365-2141.1998.00606.x", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1046/j.1365-2141.2003.04613.x", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1002/cncr.22032", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "author": "Sood R", "volume": "91", "first-page": "3372", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0048", "DOI": "10.1007/s11864-003-0004-0", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1016/j.leukres.2008.11.025", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1111/j.1365-2141.1995.tb05587.x", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1016/S0037-1963(03)00134-3", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "DOI": "10.1172/JCI114168", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "author": "Hart DN", "volume": "79", "first-page": "2116", "year": "1992", "journal-title": "Blood"}, {"key": "CIT0054", "DOI": "10.1038/sj.bmt.1703796", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "author": "Stromberg PC", "volume": "119", "first-page": "517", "year": "1985", "journal-title": "Am J Pathol"}, {"key": "CIT0056", "DOI": "10.1177/030098588302000606", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.1093/toxsci/kfm098", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1182/blood-2010-02271080", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "author": "Robertson MJ", "volume": "24", "first-page": "406", "year": "1996", "journal-title": "Exp Hematol"}, {"key": "CIT0060", "DOI": "10.1038/35095508", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "author": "Zhang J", "volume": "1", "first-page": "186", "year": "2004", "journal-title": "Cell Mol Immunol"}, {"key": "CIT0062", "author": "Liu JH", "volume": "100", "first-page": "1449", "year": "2002", "journal-title": "Blood"}, {"key": "CIT0063", "DOI": "10.1182/blood-2007-11-121871", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1038/nrm2335", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1016/j.bbamem.2006.08.019", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1016/S0167-4781(02)00529-8", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.1038/sj.bjp.0705055", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.1038/ni1523", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1111/j.1749-6632.1998.tb09658.x", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1016/j.pharmthera.2007.04.006", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1586/ern.10.193", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1038/nrd3248", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1084/jem.192.5.601", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "DOI": "10.1002/pros.10350", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1016/S1388-1981(02)00338-4", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1007/s00280-009-1177-4", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "author": "Basu S", "volume": "243", "first-page": "5802", "year": "1968", "journal-title": "J Biol Chem"}, {"key": "CIT0078", "DOI": "10.1007/978-1-4419-6741-1_11", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1038/sj.cdd.4400428", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "DOI": "10.1053/gast.2002.34753", "doi-asserted-by": "publisher"}, {"key": "CIT0081", "DOI": "10.1172/JCI200422222", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1158/0008-5472.CAN-03-1656", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1016/j.bcp.2008.02.016", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.1038/35065000", "doi-asserted-by": "publisher"}, {"key": "CIT0085", "author": "Epling-Burnette PK", "volume": "23", "first-page": "9220", "year": "2004", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1208122", "doi-asserted-by": "crossref"}, {"key": "CIT0086", "DOI": "10.1182/blood-2008-02-136382", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.2174/156800906779010227", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "DOI": "10.1073/pnas.0604042103", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "DOI": "10.1172/JCI9940", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "DOI": "10.1016/S1535-6108(03)00248-4", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "DOI": "10.1084/jem.20020307", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "DOI": "10.1182/blood-2005-08-3076", "doi-asserted-by": "publisher"}, {"key": "CIT0093", "author": "Heldin CH", "volume": "79", "first-page": "1283", "year": "1999", "journal-title": "Physiol Rev", "DOI": "10.1152/physrev.1999.79.4.1283", "doi-asserted-by": "crossref"}, {"key": "CIT0094", "DOI": "10.1182/blood-2009-06-223719", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "author": "Zambello R", "volume": "55", "first-page": "6140", "year": "1995", "journal-title": "Cancer Res"}, {"key": "CIT0096", "DOI": "10.1182/blood-2004-10-4045", "doi-asserted-by": "publisher"}, {"key": "CIT0097", "DOI": "10.1189/jlb.0107073", "doi-asserted-by": "publisher"}, {"key": "CIT0098", "DOI": "10.1016/0145-2126(94)90078-7", "doi-asserted-by": "publisher"}, {"key": "CIT0099", "DOI": "10.1046/j.1365-2141.1998.00691.x", "doi-asserted-by": "publisher"}, {"key": "CIT0100", "DOI": "10.1111/j.1365-2141.2006.06429.x", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.593276", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 12]], "date-time": "2019-06-12T23:34:44Z", "timestamp": 1560382484000}, "score": 20.98193, "issued": {"date-parts": [[2011, 7, 13]]}, "references-count": 100, "journal-issue": {"published-online": {"date-parts": [[2011, 9, 29]]}, "published-print": {"date-parts": [[2011, 12]]}, "issue": "12"}, "alternative-id": ["10.3109/10428194.2011.593276"], "URL": "http://dx.doi.org/10.3109/10428194.2011.593276", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T23:42:21Z", "timestamp": 1575502941853}, "reference-count": 12, "publisher": "Oxford University Press (OUP)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014, 8, 1]]}, "DOI": "10.1309/ajcp1jlyxlgdnoch", "type": "journal-article", "created": {"date-parts": [[2014, 7, 11]], "date-time": "2014-07-11T19:19:07Z", "timestamp": 1405106347000}, "page": "243-247", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Cutaneous Intravascular Natural Killer\u2013Cell Lymphoma"], "prefix": "10.1093", "volume": "142", "author": [{"given": "Yanli", "family": "Liu", "sequence": "first", "affiliation": [{"name": "Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei Province, China."}]}, {"given": "Wen", "family": "Zhang", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei Province, China."}]}, {"given": "Jie", "family": "An", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei Province, China."}]}, {"given": "Hui", "family": "Li", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei Province, China."}]}, {"given": "Shuang", "family": "Liu", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei Province, China."}]}], "member": "286", "published-online": {"date-parts": [[2014, 8, 1]]}, "reference": [{"key": "key\n\t\t\t\t20180602033025_b1-1420243", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1016/j.jaad.2006.12.022", "article-title": "Intravascular cytoxic T-cell lymphoma: a case report and review of the literature", "volume": "58", "author": "Gleason", "year": "2008", "journal-title": "J Am Acad Dermatol"}, {"key": "key\n\t\t\t\t20180602033025_b2-1420243", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1002/cncr.11107", "article-title": "Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop", "volume": "97", "author": "Santucci", "year": "2003", "journal-title": "Cancer"}, {"key": "key\n\t\t\t\t20180602033025_b3-1420243", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1309/X597G3QMXAFBCM5V", "article-title": "First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic and molecular features", "volume": "123", "author": "Wu", "year": "2005", "journal-title": "Am J Clin Pathol"}, {"key": "key\n\t\t\t\t20180602033025_b4-1420243", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1097/01.pas.0000213263.99973.09", "article-title": "Cutaneous intravascular NK-cell lymphoma: report of a rare variant associated with Epstein-Barr virus", "volume": "30", "author": "Kuo", "year": "2006", "journal-title": "Am J Surg Pathol"}, {"key": "key\n\t\t\t\t20180602033025_b5-1420243", "doi-asserted-by": "crossref", "first-page": "1279", "DOI": "10.1200/JCO.2006.09.9259", "article-title": "Intravascular large cell lymphoma of the natural killer cell type", "volume": "25", "author": "Song", "year": "2007", "journal-title": "J Clin Oncol"}, {"key": "key\n\t\t\t\t20180602033025_b6-1420243", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1097/PAS.0b013e31815d29c9", "article-title": "Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection", "volume": "32", "author": "Cerroni", "year": "2008", "journal-title": "Am J Surg Pathol"}, {"key": "key\n\t\t\t\t20180602033025_b7-1420243", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1600-0609.2008.01089.x", "article-title": "NK-cell intravascular lymphomatosis\u2014a mini-review", "volume": "81", "author": "Nakamichi", "year": "2008", "journal-title": "Eur J Haematol"}, {"key": "key\n\t\t\t\t20180602033025_b8-1420243", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1016/S0046-8177(00)80223-3", "article-title": "Lack of CD29 (beta1 integrin) and CD54 (ICAM-1) adhesion molecules in intravascular lymphomatosis", "volume": "31", "author": "Ponzoni", "year": "2000", "journal-title": "Hum Pathol"}, {"key": "key\n\t\t\t\t20180602033025_b9-1420243", "first-page": "472", "article-title": "Cutaneous intravascular natural killer-cell lymphoma: a rare case and review of the literature", "volume": "91", "author": "Liao", "year": "2012", "journal-title": "Acta Derm Venereol"}, {"key": "key\n\t\t\t\t20180602033025_b10-1420243", "first-page": "689", "article-title": "Intravascular NK-cell lymphoma clinical pathology analysis", "volume": "40", "author": "Jiang", "year": "2012", "journal-title": "J Pathol"}, {"key": "key\n\t\t\t\t20180602033025_b11-1420243", "first-page": "151", "article-title": "Skin intravascular NK/T cell lymphoma", "volume": "45", "author": "Chen", "year": "2013", "journal-title": "Chin J Dermatol"}, {"key": "key\n\t\t\t\t20180602033025_b12-1420243", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1002/ijc.2910550303", "article-title": "The association between Epstein-Barr virus and Chinese Hodgkin\u2019s disease", "volume": "55", "author": "Zhou", "year": "1993", "journal-title": "Int J Cancer"}], "container-title": ["American Journal of Clinical Pathology"], "language": "en", "link": [{"URL": "http://academic.oup.com/ajcp/article-pdf/142/2/243/24997995/ajcpath142-0243.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 12]], "date-time": "2019-08-12T18:55:14Z", "timestamp": 1565636114000}, "score": 20.966328, "issued": {"date-parts": [[2014, 8, 1]]}, "references-count": 12, "journal-issue": {"published-online": {"date-parts": [[2014, 8, 1]]}, "published-print": {"date-parts": [[2014, 8, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1309/ajcp1jlyxlgdnoch", "relation": {"cites": []}, "ISSN": ["1943-7722", "0002-9173"], "issn-type": [{"value": "0002-9173", "type": "print"}, {"value": "1943-7722", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:25:22Z", "timestamp": 1574796322739}, "publisher-location": "New York, NY", "reference-count": 10, "publisher": "Springer New York", "isbn-type": [{"value": "9781493936823", "type": "print"}, {"value": "9781493936847", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-1-4939-3684-7_13", "type": "book-chapter", "created": {"date-parts": [[2016, 5, 13]], "date-time": "2016-05-13T10:46:41Z", "timestamp": 1463136401000}, "page": "151-165", "source": "Crossref", "is-referenced-by-count": 10, "title": ["The Planar Lipid Bilayer System Serves as a Reductionist Approach for Studying NK Cell Immunological Synapses and Their Functions"], "prefix": "10.1007", "author": [{"given": "Grant", "family": "Bertolet", "sequence": "first", "affiliation": []}, {"given": "Dongfang", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 5, 14]]}, "reference": [{"issue": "5425", "key": "13_CR1", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1126/science.285.5425.221", "volume": "285", "author": "A Grakoui", "year": "1999", "unstructured": "Grakoui A, Bromley SK, Sumen C et al (1999) The immunological synapse: a molecular machine controlling T cell activation. Science 285(5425):221\u2013227", "journal-title": "Science"}, {"issue": "1", "key": "13_CR2", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/0304-4157(86)90016-X", "volume": "864", "author": "HM McConnell", "year": "1986", "unstructured": "McConnell HM, Watts TH, Weis RM et al (1986) Supported planar membranes in studies of cell-cell recognition in the immune system. Biochim Biophys Acta 864(1):95\u2013106", "journal-title": "Biochim Biophys Acta"}, {"issue": "1", "key": "13_CR3", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/j.immuni.2009.05.009", "volume": "31", "author": "D Liu", "year": "2009", "unstructured": "Liu D, Bryceson YT, Meckel T et al (2009) Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity 31(1):99\u2013109", "journal-title": "Immunity"}, {"issue": "4", "key": "13_CR4", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1016/j.immuni.2012.03.007", "volume": "36", "author": "D Liu", "year": "2012", "unstructured": "Liu D, Peterson ME, Long EO (2012) The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity 36(4):600\u2013611", "journal-title": "Immunity"}, {"issue": "4", "key": "13_CR5", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1083/jcb.201009135", "volume": "192", "author": "TP Abeyweera", "year": "2011", "unstructured": "Abeyweera TP, Merino E, Huse M (2011) Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J Cell Biol 192(4):675\u2013690", "journal-title": "J Cell Biol"}, {"key": "13_CR6", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.3389/fimmu.2013.00410", "volume": "4", "author": "TP Abeyweera", "year": "2013", "unstructured": "Abeyweera TP, Kaissar M, Huse M (2013) Inhibitory receptor signaling destabilizes immunological synapse formation in primary NK cells. Front Immunol 4:410. doi: 10.3389/fimmu.2013.00410", "journal-title": "Front Immunol"}, {"key": "13_CR7", "unstructured": "Zheng P, Bertolet G, Chen Y, Huang S, Liu D (2015) Super-resolution imaging of the natural killer cell immunological synapses on a glass-supported planar lipid bilayer. J Vis Exp 96. doi: 10.3791/52502 . (PMCID: PMC4354632)", "DOI": "10.3791/52502", "doi-asserted-by": "crossref"}, {"issue": "9", "key": "13_CR9", "doi-asserted-by": "crossref", "first-page": "e1001151", "DOI": "10.1371/journal.pbio.1001151", "volume": "9", "author": "GD Rak", "year": "2011", "unstructured": "Rak GD, Mace EM, Banerjee PP et al (2011) Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol 9(9):e1001151. doi: 10.1371/journal.pbio.1001151", "journal-title": "PLoS Biol"}, {"issue": "9", "key": "13_CR10", "doi-asserted-by": "crossref", "first-page": "e1001152", "DOI": "10.1371/journal.pbio.1001152", "volume": "9", "author": "AC Brown", "year": "2011", "unstructured": "Brown AC, Oddos S, Dobbie IM et al (2011) Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. PLoS Biol 9(9):e1001152. doi: 10.1371/journal.pbio.1001152", "journal-title": "PLoS Biol"}, {"issue": "6", "key": "13_CR11", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1084/jem.20112741", "volume": "209", "author": "T Yokosuka", "year": "2012", "unstructured": "Yokosuka T, Takamatsu M, Kobayashi-Imanishi W et al (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med 209(6):1201\u20131217", "journal-title": "J Exp Med"}], "container-title": ["Natural Killer Cells", "Methods in Molecular Biology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-3684-7_13", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T13:36:17Z", "timestamp": 1498311377000}, "score": 20.901268, "issued": {"date-parts": [[2016]]}, "ISBN": ["9781493936823", "9781493936847"], "references-count": 10, "URL": "http://dx.doi.org/10.1007/978-1-4939-3684-7_13", "relation": {"cites": []}, "ISSN": ["1064-3745", "1940-6029"], "issn-type": [{"value": "1064-3745", "type": "print"}, {"value": "1940-6029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T10:40:24Z", "timestamp": 1575196824413}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 3, 8]]}, "DOI": "10.3410/f.717980750.793471780", "type": "dataset", "created": {"date-parts": [[2013, 3, 8]], "date-time": "2013-03-08T13:08:38Z", "timestamp": 1362748118000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity."], "prefix": "10.3410", "author": [{"given": "Ashraf", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"given": "Mingfu", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2013, 2, 26]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2013, 3, 8]], "date-time": "2013-03-08T13:08:39Z", "timestamp": 1362748119000}, "score": 20.901268, "issued": {"date-parts": [[2013, 2, 26]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.717980750.793471780"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T02:11:03Z", "timestamp": 1575252663746}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 7, 19]]}, "DOI": "10.3410/f.718009656.793479962", "type": "dataset", "created": {"date-parts": [[2013, 7, 19]], "date-time": "2013-07-19T10:49:38Z", "timestamp": 1374230978000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for Targeting of a natural killer cell receptor family by a viral immunoevasin."], "prefix": "10.3410", "author": [{"given": "Xiaojing", "family": "Ma", "sequence": "first", "affiliation": []}, {"given": "Xin", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2013, 7, 10]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2013, 7, 19]], "date-time": "2013-07-19T10:49:38Z", "timestamp": 1374230978000}, "score": 20.901268, "issued": {"date-parts": [[2013, 7, 10]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.718009656.793479962"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T23:05:26Z", "timestamp": 1574895926108}, "reference-count": 52, "publisher": "Baishideng Publishing Group Inc.", "issue": "13", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["WJCC"], "published-print": {"date-parts": [[2018, 11, 6]]}, "DOI": "10.12998/wjcc.v6.i13.694", "type": "journal-article", "created": {"date-parts": [[2018, 11, 6]], "date-time": "2018-11-06T04:37:31Z", "timestamp": 1541479051000}, "page": "694-702", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Natural killer/T-cell lymphoma with concomitant syndrome of inappropriate antidiuretic hormone secretion: A case report and review of literature"], "prefix": "10.12998", "volume": "6", "author": [{"given": "Quan-Bo", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Rui", "family": "Zheng", "sequence": "additional", "affiliation": []}], "member": "2060", "reference": [{"key": "ref1", "DOI": "10.1186/1750-9378-9-38", "doi-asserted-by": "publisher"}, {"key": "ref2", "DOI": "10.1056/NEJM200005253422107", "doi-asserted-by": "publisher"}, {"key": "ref3", "DOI": "10.1016/j.amjmed.2013.07.006", "doi-asserted-by": "publisher"}, {"key": "ref4", "DOI": "10.3109/0284186X.2016.1170198", "doi-asserted-by": "publisher"}, {"key": "ref5", "DOI": "10.1182/blood-2016-01-643569", "doi-asserted-by": "publisher"}, {"key": "ref6", "DOI": "10.1586/17446651.1.4.537", "doi-asserted-by": "publisher"}, {"key": "ref7", "DOI": "10.1111/j.1365-2141.2008.07255.x", "doi-asserted-by": "publisher"}, {"key": "ref8", "DOI": "10.1111/j.1365-2141.2012.09090.x", "doi-asserted-by": "publisher"}, {"key": "ref9", "DOI": "10.7534/j.issn.1009-2137.2017.02.027", "doi-asserted-by": "publisher"}, {"key": "ref10", "DOI": "10.1016/0002-9343(67)90096-4", "doi-asserted-by": "publisher"}, {"key": "ref11", "DOI": "10.1111/cen.13243", "doi-asserted-by": "publisher"}, {"key": "ref12", "DOI": "10.1038/ki.1974.37", "doi-asserted-by": "publisher"}, {"key": "ref13", "DOI": "10.1530/EJE-10-1078", "doi-asserted-by": "publisher"}, {"key": "ref14", "DOI": "10.1016/0026-0495(88)90028-5", "doi-asserted-by": "publisher"}, {"key": "ref15", "DOI": "10.1016/s0889-8529(03)00004-5", "doi-asserted-by": "publisher"}, {"key": "ref16", "DOI": "10.1016/j.ejim.2015.10.020", "doi-asserted-by": "publisher"}, {"key": "ref17", "DOI": "10.1136/bcr-2012-007147", "doi-asserted-by": "publisher"}, {"key": "ref18", "DOI": "10.1007/BF01715383", "doi-asserted-by": "publisher"}, {"key": "ref19", "DOI": "10.3109/10428190109097769", "doi-asserted-by": "publisher"}, {"key": "ref20", "DOI": "10.2169/internalmedicine.46.0252", "doi-asserted-by": "publisher"}, {"key": "ref21", "unstructured": "Polprasert C, Wongjitrat C, Wisedopas N. Case report: severe CMV colitis in a patient with follicular lymphoma after chemotherapy. J Med Assoc Thai 2011; 94: 498-500"}, {"key": "ref22", "DOI": "10.1038/sj.bmt.1701922", "doi-asserted-by": "publisher"}, {"key": "ref23", "DOI": "10.1007/s002770000188", "doi-asserted-by": "publisher"}, {"key": "ref24", "DOI": "10.1186/1472-6823-13-19", "doi-asserted-by": "publisher"}, {"key": "ref25", "DOI": "10.1111/j.1445-5994.1998.tb02982.x", "doi-asserted-by": "publisher"}, {"key": "ref26", "DOI": "10.1159/000109979", "doi-asserted-by": "publisher"}, {"key": "ref27", "DOI": "10.1002/ajh.20827", "doi-asserted-by": "publisher"}, {"key": "ref28", "DOI": "10.1007/s00277-011-1196-1", "doi-asserted-by": "publisher"}, {"key": "ref29", "DOI": "10.1016/j.clml.2012.03.001", "doi-asserted-by": "publisher"}, {"key": "ref30", "DOI": "10.1111/bjh.12891", "doi-asserted-by": "publisher"}, {"key": "ref31", "DOI": "10.1093/annonc/mdu436.102", "doi-asserted-by": "publisher"}, {"key": "ref32", "DOI": "10.1007/s13730-015-0200-3", "doi-asserted-by": "publisher"}, {"key": "ref33", "DOI": "10.2169/internalmedicine.9048-17", "doi-asserted-by": "publisher"}, {"key": "ref34", "unstructured": "Sun Y, Lin S, Lin KY, Li WM, Xu W, Zeng LY. Extranodal nasal type natural killer/T-cell lymphoma with refractory hyponatremia: A case report and literature review. Tumor 2018; 38: 140-144"}, {"key": "ref35", "DOI": "10.1016/j.ejphar.2016.02.064", "doi-asserted-by": "publisher"}, {"key": "ref36", "DOI": "10.1093/annonc/mdv486", "doi-asserted-by": "publisher"}, {"key": "ref37", "DOI": "10.1111/j.1365-2141.2008.07542.x", "doi-asserted-by": "publisher"}, {"key": "ref38", "DOI": "10.1007/bf02983788", "doi-asserted-by": "publisher"}, {"key": "ref39", "DOI": "10.1210/jc.79.4.934", "doi-asserted-by": "publisher"}, {"key": "ref40", "DOI": "10.1093/annonc/mdp064", "doi-asserted-by": "publisher"}, {"key": "ref41", "DOI": "10.1007/s11899-012-0132-3", "doi-asserted-by": "publisher"}, {"key": "ref42", "DOI": "10.1158/1078-0432.Ccr-0670-3", "doi-asserted-by": "publisher"}, {"key": "ref43", "DOI": "10.1098/rstb.2016.0271", "doi-asserted-by": "publisher"}, {"key": "ref44", "DOI": "10.1097/00001622-199909000-00002", "doi-asserted-by": "publisher"}, {"key": "ref45", "DOI": "10.1046/j.1365-2141.2003.04335.x", "doi-asserted-by": "publisher"}, {"key": "ref46", "DOI": "10.1634/theoncologist.2008-0036", "doi-asserted-by": "publisher"}, {"key": "ref47", "unstructured": "Li X, Li G, Gao Z, Zhou X, Zhu X. The relative frequencies of lymphoma subtypes in china: a nationwide study of 10002 cases by the chinese lymphoma study group. Ann Oncol 2011; 22: 141"}, {"key": "ref48", "DOI": "10.1097/PAS.0b013e31826731b5", "doi-asserted-by": "publisher"}, {"key": "ref49", "DOI": "10.1200/jco.2000.18.1.54", "doi-asserted-by": "publisher"}, {"key": "ref50", "DOI": "10.1023/a:1011144911781", "doi-asserted-by": "publisher"}, {"key": "ref51", "DOI": "10.1016/s0360-3016(02)02916-4", "doi-asserted-by": "publisher"}, {"key": "ref52", "DOI": "10.5045/br.2013.48.4.274", "doi-asserted-by": "publisher"}], "container-title": ["World Journal of Clinical Cases"], "link": [{"URL": "http://www.wjgnet.com/2307-8960/full/v6/i13/694.htm", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 6]], "date-time": "2018-11-06T04:38:27Z", "timestamp": 1541479107000}, "score": 20.527624, "issued": {"date-parts": [[2018, 11, 6]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2018, 11, 6]]}, "issue": "13"}, "URL": "http://dx.doi.org/10.12998/wjcc.v6.i13.694", "relation": {"cites": []}, "ISSN": ["2307-8960"], "issn-type": [{"value": "2307-8960", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}